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“You cannot hope to build a better world without improving the individuals. To that end, 
each of us must work for our own improvement and, at the same time, share a general 
responsibility for all humanity, our particular duty being to aid those to whom we think 
can be most useful.” 
—Marie Curie, Autobiographical Notes, 1923 
 
 
(Curie, 1923) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
This thesis was carried out at the Max Planck Institute for Biology of Aging (Cologne, 
Germany). Without the support and funding of the Max Planck society, this project could 
not have reached its goal. 
First, I would like to express my deepest gratitude to my supervisor PhD James Stewart, for 
giving me the opportunity to join his research group. You allowed me to pursue my doctoral 
degree in an incredible stimulating scientific environment, and it was truly a life-changing 
experience. Many thanks for the support, patience and trust. I am very grateful that 
sometimes you gave me the freedom to experiment and let me pursue some of my own 
ideas. A big thank you for always taking the time to answer my questions. May the force be 
with you.  
I want to thank Prof. Dr. Aleksandra Trifunovic for kindly accepting to be my official 
supervisor and be part of my evaluating committee. Here, I wish to express my sincere 
admiration for your remarkable research work and dedication to science. 
I am also grateful to Prof. Dr. Rudolf J. Wiesner, and Prof. Dr. Jan Riemer for accepting, 
without hesitation, to be part of the evaluating thesis committee. In special to Prof. Dr. 
Wiesner, for his scientific input during the analysis of the immune response data and for the 
invaluable scientific input during all the supervising meetings.  
Importantly, I would like to acknowledge Dr. Min Jiang and Dr. Prof. Nils Larsson, for 
invite me to collaborate in one of their research projects, leading to a publication (Jiang et 
al., 2017) during my time as PhD student. Dr. Jiang also provided me with enormous support 
for the mouse fertility assays. But above everything, she provided me with invaluable 
friendship, endless happy moments and tons of delicious Chinese cuisine.  
None of the work would have been possible without the support of the Larsson research 
group, especially Elisa, Maria del Pilar, Eduardo, Nina, Timo and Johanna, who kindly 
shared their technical knowledge with me. Additionally, the MPI-AGE core facilities 
always provided with high quality support during this research.  
   
Special thanks goes to Marie-Lune Simard, who not only provided technical support during 
NBTx stainings but also did not hesitate to offer her true friendship since the first moment. 
I will miss you, my DJ scientist. To Marita and Pamella, my Stewart’s Lab colleagues and 
friends, with whom I shared the ups and downs of science. To my lab friends, the Spicygirls 
(Francesca, Min, Avan and Elisa), with whom I shared a lot of dances, dinners and joy. And 
to all members of the MPI-AGE that created a warm and friendly scientific atmosphere. 
A big hug and thanks to my dear Mexican friends Daniel, Tona, and all the scientific latin 
gang. Since you arrived, home was not so far away anymore because you brought colours 
and flavours back to my life. Gracias. 
I wish to acknowledge the support and great love of my family. My parents Josué and 
Martha, who are one of the main driving forces that keeps me going. Los amo muchísimo y 
siempre están en mi corazón. My grandmother Maria, who has always been an example of 
strength. Finally, my amazing husband Robert Meyer, who has been giving me immense 
happiness, peace and support during all these years. In deinen Armen habe ich ein neues 
Zuhause gefunden.  
I will always treasure all the moments I spend doing this research. Although science can be 
an obscure territory, the sparks I was capable to see have illuminated my world. 
 
 
Table of Content 
ABSTRACT ........................................................................................................ 18 
ZUSAMMENFASSUNG ............................................................................................................. 20 
1.  INTRODUCTION ............................................................................................................. 17 
1.1.  MITOCHONDRIA: AN OVERVIEW ....................................................................................... 17 
1.1.1.  History of Mitochondrial research                      17 
1.1.2.  Origen and evolution of mitochondria                    19 
1.1.3.  Structural organization and functions of mitochondria                21 
1.2.  MAMMALIAN MITOCHONDRIAL DNA ............................................................................. 24 
1.2.1.  Genome organization                        24 
1.2.2.  mtDNA structural organization and characteristics                26 
1.3.  MTDNA REPLICATION ......................................................................................................... 27 
1.3.1.  Replisome                            27 
1.3.2.  Replication model                          27 
1.3.3.  D‐loop                            29 
1.4.  MITOCHONDRIAL POLYMERASE ........................................................................................ 30 
1.4.1.  Mitochondrial polymerase holoenzyme functions                30 
1.4.2.  POLG catalytic subunit                        31 
1.4.3.  POLG related disorders                        32 
1.5.  POLG MUTATOR MOUSE MODEL ..................................................................................... 35 
1.5.1.  History of POLG mutator mouse models                    35 
1.5.2.  Phenotype of mitochondrial POLG mutator mice                36 
1.5.3.  Mutator mouse as a research model                    39 
2.  RESEARCH AIMS .............................................................................................................. 42 
3.  RESULTS .............................................................................................................................. 44 
3.1.  DESCRIPTION, GENERATION AND MAINTENANCE OF MTDNA MUTATOR        
MOUSE LINES. ....................................................................................................................... 44 
3.2.  INCREASED CARDIOMYOPATHY AND ANAEMIA IN MICE WITH THE LAR ALLELE ... 46 
   
3.3.  MALE MUTATORS WITH LAR ALLELE ARE STERILE WHILE MUTATORS WITH         
PRO ALLELE REMAIN FERTILE ........................................................................................... 48 
3.4.  LIFESPAN COMPARISON DEMONSTRATE ALLELE HYPOTHESIS .................................... 53 
3.5.  TRANSCRIPTOME ANALYSIS REVEALS A DIFFERENTIAL IMMUNE RESPONSE  
BETWEEN MUTATORS WITH DIFFERENT ALLELES  ........................................................ 54 
3.6.  SNPS ON THE POLG PRO ALLELE AND POSSIBLE CONSEQUENCES .......................... 58 
3.7.  POLG PROTEIN LEVELS ARE NOT AFFECTED BY THE ALLELE EXPRESSED ................. 63 
3.8.  MUTATION RATES AND COX‐DEFICIENCY DIFFERENCES BETWEEN LAR AND      
PRO ALLELE .......................................................................................................................... 64 
3.9.  DIFFERENCES IN REPLICATION BETWEEN LAR AND PRO ALLELE ............................... 68 
4.  DISCUSSION ...................................................................................................................... 74 
5.  CONCLUSIONS AND FUTURE PERSPECTIVES .................................................. 83 
6.  SUPPLEMENTARY FIGURES ....................................................................................... 85 
7.  MATERIALS AND METHODS ..................................................................................... 95 
7.1.  GENERATION AND MAINTENANCE OF MICE .................................................................. 95 
7.1.1.  Mouse husbandry                                     95 
7.1.2.  Maintenance and generation of mutant mice                                95 
7.2.  MOLECULAR BIOLOGY METHODS ..................................................................................... 96 
7.2.1.  Mouse genotyping                       96 
7.2.2.  Blood cell count                                       97 
7.2.3.  mtDNA extraction                                       97 
7.2.4.  Total DNA extraction                                              98 
7.2.5.  Total RNA extraction                                    99 
7.2.6.  cDNA Synthesis                                       99 
7.2.7.  qPCR and RT‐qPCR                                      99 
7.2.8.  Southern blotting                                      100 
7.2.9.  In organello replication assay                            101 
7.2.10.    Isolation of mitochondria from heart                                        102 
7.2.11.  Sperm analysis                                      102 
 
   
7.3.  BIOCHEMICAL METHODS .................................................................................................. 103 
7.3.1.  DC protein assay                        103 
7.3.2.  Western blotting                        103 
7.3.3.  NBTx staining                        104 
7.3.4.  COX‐SDH staining                        104 
7.3.5.  H&E staining                         105 
7.3.6.  Toloudine staining                        105 
7.4.  SEQUENCING ........................................................................................................................ 105 
7.4.1.  RNA Sequencing and Data analysis                  105 
7.4.2.  mtDNA sequencing                        106 
7.4.3.  Pyrosequencing                        106 
7.5.  STATISTICAL ANALYSIS ....................................................................................................... 107 
7.5.1.  Data graphic and statistical analysis                  107 
8.  REFERENCES ................................................................................................................... 108 
9.  SUPPLEMENTARY LISTS ............................................................................................ 133 
9.1.  LIST OF ABBREVIATIONS ................................................................................................... 133 
9.2.  LIST OF FIGURES ................................................................................................................. 137 
9.3.  LIST OF SUPPLEMENTARY FIGURES ................................................................................. 138 
9.4.  LIST OF TABLES ................................................................................................................... 138 
10.  ERKLÄRUNG .................................................................................................................... 139 
11.  CURRICULUM VITAE ................................................................................................... 140 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
The mtDNA mutator mouse model contains a D257A mutation in the exonuclease domain 
of the POLG gene, which generates a mouse with an increased number of mtDNA 
mutations. The mouse shows several characteristics of premature ageing. To date, three 
mutators with the same POLG mutation have been described in the literature. However, 
they show remarkable differences in lifespan and the time when the ageing phenotype 
appears.  
This study has demonstrated that although the genetic background influences to some 
degree the ageing phenotype, the main cause of the phenotypical differences exhibited by 
two of the mutator mice strains is due to the POLG allele expressed (Lar allele versus the 
Pro allele) and not the nuclear genetic background.  
In addition, my work has revealed that the Pro allele generates a variant protein product of 
POLG, and as a result, the mutator mouse with this variant shows a slightly different 
phenotype than the mutator with the Lar allele. Pro mutator mouse phenotype differences 
include male fertility, increased lifespan, slower onset of the ageing phenotypes, reduced 
mutation rate, reduced mitochondrial dysfunction and different replicative activity.  
 
 
 
 
  
 
 
 
 
 
 
 
ZUSAMMENFASSUNG 
 
Das mtDNA-Mutator-Mausmodell enthält eine D257A Mutation in der Exonuklease-
Domäne der POLG, die eine Maus mit einem mitochondrialen POLG-defizienten Protein 
erzeugt. Die Maus weist mehrere Charakteristika vorzeitigen Alterns auf. Bisher wurden 
drei Mutator-Mausmodelle mit der gleichen POLG Mutation beschrieben. Allerdings 
weisen diese bemerkenswerte Unterschiede in ihrer Lebenserwartung und dem Zeitpunkt, 
an dem der Alterungsphänotyp in Erscheinung tritt, auf. 
Obwohl der genetische Hintergrund zu einem gewissen Grad den Alterungsphänotyp 
beeinflusst, hat meine Arbeit gezeigt, dass die Hauptursache für die phänotypischen 
Unterschiede bei den Mutator-Mäusen die exprimierten Allele sind, und nicht der 
genetische Hintergrund. 
Darüber hinaus hat meine Arbeit offenbart, dass das Pro-Allel eine Variante der POLG 
generiert und, als Ergebnis, die Mutator-Maus mit dieser Variante einen geringfügig 
anderen Phänotyp aufweist als die Mutator-Maus mit dem Lar-Allel. Die phänotypischen 
Unterschiede der Pro-Mutator-Maus umfassen die männliche Fruchtbarkeit, eine erhöhte 
Lebensdauer, einen milderen Alterungsphänotyp, eine verminderte Mutationsrate, 
reduzierte mitochondriale Dysfunktion und eine andere replikative Aktivität. 
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1. INTRODUCTION 
1.1. Mitochondria: an overview 
?????? ??????????? ??????????????????????
The first descriptions of intracellular structures go back to the 1840s (Ernster and Schatz, 
1981). Nevertheless, it was not until 1890 that Richard Altmann, a German pathologist, 
reported in his book Die Elementarorganismen Und Ihre Beziehungen Zu Den Zellen (The 
elementary organisms and their relations to the cells) some structures he named “bioblasts” 
(life germs) (Figure 1-1A). He described these structures as elementary organisms living 
inside the cells, and he postulated that they carry out vital metabolic functions for the cell 
(Altmann, 1890). However, his book was received with criticism and scepticism, and it took 
almost 20 years until his ideas were taken into consideration (Cowdry, 1953).  
In the meantime, Carl Benda identified some structures during his research on 
spermatogenesis. He called the unit “mitochondrion”, from the Greek mitos (thread) and 
chondros (granule), coining the word in 1898. Two years later, Michaelis was able to stain 
specific mitochondria using Janus Green B dye. This technique allowed researchers (like 
Meves, Cowdry, among others) to discovered that cells from plants, protozoa, and animals 
contain mitochondria, leading to speculation that mitochondria may play an important role 
in cells (Cowdry, 1953; Ernster and Schatz, 1981).  
Over the following years, several theories about the role of mitochondria flourished. For 
instance, the role of mitochondria in genetic inheritance by Payne in 1909 (albeit maternal), 
the beginning of endosymbiotic theory by Wallin in 1927, and several energy metabolism 
studies (Reviewed by Ernster and Schatz, 1981).  
However, it was not until the development of methods to isolate mitochondria in 1934 and 
1948 that the stage for a more thorough mitochondrial analysis was set. These methods 
included the isolation of mitochondria by cell fractionation (Bensley and Hoerr, 1934) and 
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the addition of sucrose solution during fractionation (Hogeboom et al., 1948).  In 1952, the 
first electron micrograph of the mitochondria was obtained (Figure 1-1B) (Palade, 1952).  
 
 
Figure 1-1. Mitochondria through time. A) The first representation of structures (bioblasts) by 
Richard Altmann in 1890. Sketch of a longitudinal section through the muscle of the adult frog. Staining 
using mercury mixture with formic acid (Altmann, 1890). B) First Electron micrograph of the 
mitochondrion from nephron rat embryo by Palade in 1952. Mitochondrion from nephron rat embryo 
(Palade, 1952). Figure license Number 4735620866487 by John Wiley & Sons and Copyright 
Clearance Center. C) and D) Contemporary view of mitochondria. C) Transmission electron 
microscopy of mitochondria from a thin section cut of mammalian lung tissue. Author: Louisa Howard, 
year 2008. Figure of public domain at: https://commons.wikimedia.org/wiki/ 
File:Mitochondria,_mammalian_lung_-_TEM.jpg. D) Computer reconstructed Cryo-electron 
tomography. The figure is a representation of bovine heart mitochondrion. Nucleoids are shown in blue 
and green structures are cristae (Gustafsson et al., 2016). Figure license Number 1018149-1 by John 
Wiley & Sons and Copyright Clearance Center. 
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In the biochemical field, some big steps were made. For example, during the 1950s it was 
demonstrated that mitochondria contain enzymes for the citric acid cycle, fatty acid 
oxidation and phosphorylation. The membrane-localization of the respiratory chain 
complexes was also reported (Reviewed by Ernster and Schatz, 1981). Because of research 
during these years, mitochondrion was termed the “Powerhouse of the cell” in a paper of 
the same name (Siekevitz, 1957).  In 1963 an incredible discovery was reported. The 
electron micrographs from chick embryo cells evidenced that mitochondria contained 
threadlike structures. Moreover, these structures were sensitive to digestion with DNases, 
implying that mitochondria (and chloroplasts) contained their own DNA (Nass and Nass, 
1963). Months later, DNA from yeast mitochondria was purified using biochemical 
procedures (Schatz et al., 1964). This research finally confirmed that mitochondria contain 
their own DNA (mtDNA). All these discoveries formed the basis for a completely new and 
exciting field of cell biology, which, with the use of new technologies has grown rapidly. 
 
 
?????? ???????????????????????? ????????????
To date, genomic and cell biology research has revealed that all eukaryotes are derived from 
a single common ancestor, termed LECA (last eukaryotic common ancestor). It is generally 
accepted that LECA originates approx. 1.2 billion years ago (but the estimates can vary 
twofold), when an archaeon cell entered into an endosymbiotic relationship with an α-
proteobacterium. Nevertheless, controversy persists about the precise lineage of the 
proteobacterium (Gray, 2012; Martijn et al., 2018), how closely related they are to 
mitochondria (Boussau et al., 2004), and the nature of the cell that engulfed the 
proteobacterium (Martin et al., 2001). 
Since not all eukaryotes followed the same evolutionary pattern, mitochondria have drastic 
differences in terms of function among organisms. In accordance with their energy 
metabolism, mitochondria have been classified as aerobic mitochondria, anaerobic 
mitochondria, hydrogen-producing mitochondria, hydrogenosomes and mitosomes (Muller 
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et al., 2012). Despite the single exception of Monocercomonoides sp. where mitochondria 
appear to have been lost (Karnkowska et al., 2016), all known eukaryotes to date possess 
mitochondria or mitochondria-related organelles (MROs) (Roger et al., 2017).  
The endosymbiotic process, where an autonomous α-proteobacterium evolved to a 
dependent organelle, has attracted much attention in the last decades. In this regard, it has 
been proposed that in order to achieve endosymbiosis, complex changes must have had 
occurred. These changes during evolution must have included: (1) acquisition of 
transporters/carriers into the mitochondrial membrane, (2) evolution of protein-import 
mitochondrial machinery, (3) integration of a communication system between host and 
symbiont, (4) re-targeting of proteins to mitochondria, (5) genome reduction through loss 
of unnecessary genes in the mitochondria, and (6) gene transfer to the nucleus (Roger et al., 
2017).  
The mitochondrial genome transfer to the nucleus has raised many questions and debates. 
The major debate focuses on understanding why most genes were transferred from the 
symbiont to the nuclear genome, while others remained (like OXPHOS components and 
tRNAs) (Blanchard and Lynch, 2000). Several theories have been thus far proposed, for 
example, the Co-location for Redox Regulation (CoRR) hypothesis, postulates that genes 
from the electron transport chain (ETC) are maintained in the mtDNA because it allows a 
rapid regulation and gene expression during changes in the redox state (Allen, 2003). A 
second theory proposes that codon usage variations between the nucleus and organelles have 
prevented the gene transfer (Race et al., 1999).  A third hypothesis postulates that some 
large hydrophobic proteins remained encoded in the mtDNA, with multiple transmembrane 
domains, because they are difficult to import across membranes (Adams and Palmer, 2003; 
Popot and Vitry, 1990). Moreover, if they were expressed in the cytosol they could be mis-
targeted to the endoplasmic reticulum (Björkholm et al., 2017; von Heijne, 1986). Also, it 
has been discussed that mitochondrial small and large subunit rRNA genes remained 
encoded in the mtDNA since translocating large structured RNAs through mitochondrial 
membranes might be difficult (Roger et al., 2017).  
The second theory that proposes codon usage variations as the limiting step for gene transfer 
have some evidence against. For example, several genes from the α-proteobacterium have 
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already been passed to the nuclear genome (Martin, 2003; Mourier et al., 2001). Moreover, 
the universal genetic code is used by the mitochondria of green plants (Jukes and Osawa, 
1990). Therefore, this hypothesis has been largely discarded. To date, the CoRR theory has 
a strong experimental evidence. For instance, it has been demonstrated with in organello 
assays that protein synthesis is responsive to redox reagents (Allen et al., 1995; Escobar 
Galvis et al., 1998) and the transcription of chloroplast DNA can be redox regulated 
(Pfannschmidt et al., 1999; Wilson et al., 1996). In addition, these theories are not 
necessarily mutually exclusive. For instance, mtDNA genome analysis of 2015 species 
suggest that GC content and hydrophobicity are two characteristics that strongly predict if 
a gene will be retained in the mtDNA, and redox stress is known to be linked to adenine 
pools depletions, which could explain the preference to use GC-rich codons (Johnston and 
Williams, 2016).  
 
 
?????? ??????????? ????????????? ???? ?????????? ???
?????????????
There is a strong mitochondria variation among eukaryotes (Roger et al., 2017); therefore, 
in this thesis, we will just focus on mammalian mitochondria. Although mammalian 
mitochondria maintain some characters from their protobacterium ancestors, these 
organelles have undergone to several changes, transforming them into highly specialised 
structures (Roger et al., 2017).   
Mitochondria are not isolated structures, in fact, they are dynamic organelles that 
continuously change shape through fission (division of one mitochondrion into two 
daughter mitochondria) and fusion (union of two mitochondria into one mitochondrion), 
and change their position by the movement along cytoskeletal tracks (van der Bliek et al., 
2013). Mitochondrial movement was first described more than 100 years ago (Lewis and 
Lewis, 1915), but our knowledge in regard to mitochondrial dynamics has dramatically 
increased in the last 40 years because of the development of live cell imaging technology 
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(Liesa et al., 2009). Now we know that mitochondrial dynamics have a clear relevance for 
processes like cell growth and death (Westermann, 2010), immune response (Rambold and 
Pearce, 2018), mitochondrial re-distribution and mitochondrial quality control (Ni et al., 
2015).   
Mitochondria have two lipid bilayer membranes, the inner membrane (IM) and the outer-
membrane (OM), which form different compartments. Membranes and compartments 
exhibit specific functions (Friedman and Nunnari, 2014; McCarron et al., 2013). The outer-
mitochondrial membrane (OM) forms a barrier to the cytosol, mediates the import of 
proteins and lipids, and the passage of small molecules (Yamashita et al., 2016). The inter-
membrane space (IMS) contains proteins implicated in mitochondrial energetics and 
apoptosis, like cytochrome c (CytC) (McCarron et al., 2013). The inner-membrane contains 
a large amount of transporters for carrying proteins to the matrix (Wohlrab, 2009), and 
contains double-membrane interdigitations called cristae (which are the principal site of 
oxidative phosphorylation) (Cogliati et al., 2016). Finally, the matrix is the site where the 
tricarboxylic acid (TCA) cycle occurs, and where mtDNA is located in structures called 
nucleoids (Osellame et al., 2012) (Figure 1-2).  
Mitochondria are best known to be responsible for harnessing the energy released in 
oxidative metabolism of the cell, in the form of ATP. In general terms, mitochondrial 
energetic metabolism begins with the internalisation of pyruvate (generated mainly from 
glucose) and acyl-CoA (generated from fatty acids) in to the matrix. Briefly, during beta-
oxidation, fatty acids are broken down to generate acetyl-CoA (which enters the TCA 
cycle), NADH and FADH2. Pyruvate, on the other hand, will be oxidised by the pyruvate 
dehydrogenase complex and form acetyl-CoA (which will enter the TCA cycle) and NADH.  
The acetyl-CoA then enters the TCA cycle, generating more NADH and FADH2. Then, the 
electrons carried by NADH and FADH2, are transported to the oxidative phosphorylation 
system (OXPHOS), forming an electrochemical gradient that is harnessed to produce ATP 
from ADP. In the end, the ATP is transported to the cytoplasm by the ADP/ATP translocase 
(Spinelli and Haigis, 2018). Additionally, mitochondria have other critical metabolic 
functions, for instance Fe-S cluster biogenesis, metabolism of fatty acids, and is implicated 
in the metabolism of some amino acids (Spinelli and Haigis, 2018).  
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Figure 1-2. Schematic representation of mitochondrial main functions. The illustration shows the 
different functions discussed in the text. The main structures/parts in the mitochondria are IM (inner-
membrane), OM (outer-membrane), IMS (inter-membrane space), matrix and nucleoids. Important in 
oxidative respiration is the generation of ATP through the OXPHOS system (complexes I, II, III, IV, 
V). The OXPHOS system is fed by the electron transporters NADH or FADH2, which are produced 
by b-oxidation and the TCA (tricarboxylic acid) cycle. Mitochondria can also generate ROS (reactive 
oxygen species), as a side product of OXPHOS. Mitochondria are also involved in apoptosis, through 
the release of calcium and CytC (cytochrome c) by the mPTP (mitochondrial permeability transition 
pore). The majority of mitochondrial proteins are synthesized as precursors in the cytosol and later 
imported by the protein import mitochondrial machinery. In this schema, the proteins TIM and TOM 
represent the mitochondrial protein transport; however, mitochondrial machineries to import proteins 
are much more complex. Mitochondria have an important role in calcium signalling by sequestering 
and releasing Ca2+ (calcium ion), for example through calcium diffusion, calcium uniporter, sodium-
calcium exchanger and the mPTP. 
 
Moreover, this amazing organelle interacts actively with other parts of the cell and has a 
much wider range of functions. There is a vast amount of literature demonstrating the 
important role of mammalian mitochondria. For instance, in apoptosis activation through 
the release of proteins from the intermembrane space (e.g. CytC and caspases) (Tait and 
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Green, 2013), calcium signalling through the sequester and release of Ca2+ (calcium ion) 
(Giorgi et al., 2018), and ROS signalling pathway through the production of ROS during 
the OXPHOS process (Shadel and Horvath, 2015).  
 
 
1.2. Mammalian mitochondrial DNA 
?????? ?????????????????????
The size of the mtDNA varies among the species (Kolesnikov and Gerasimov, 2012). In 
humans, the mtDNA length is ∼16.5 kb (Andrews et al., 1999) while in mice it is ∼16.3 kb 
(Bayona-Bafaluy et al., 2003). Although nuclear DNA encodes 99% of the proteins required 
for mitochondrial function, mitochondrial DNA (mtDNA) is indispensable. The mammalian 
mtDNA encodes 13 polypeptides, which are necessary for the assembly and function of the 
OXPHOS system. In addition, the mtDNA encodes 22 tRNAs and 2 ribosomal RNAs, all 
necessary for mtDNA translation (Gammage and Frezza, 2019).  
Mammalian mtDNA is a double-stranded circular molecule. Each strand is named either 
heavy (H) or light (L) strand; these names were given to them due to their guanine content 
differences when human mtDNA are separated in CsCl2 gradients (Borst, 1972; Borst et al., 
1967). Specifically, from the 37 genes encoded by the mtDNA, the majority are encoded in 
the light strand and transcribed from the heavy strand: 10 mRNAs (two bi-cistronic, 
ATP8/ATP6 and Nd4l/Nd4), 2 rRNAs (12S and 16S) and 14 tRNAs. Only 1 mRNA and 8 
tRNAs are encoded in the heavy strand and transcribed from the light strand (Figure 1-3) 
(Chinnery and Hudson, 2013).  
Most of mtDNA (almost 93%) consists of coding regions. This feature, unlike nuclear DNA, 
is because mtDNA lacks intron regions and additionally genes are separated only by one or 
two base pairs (Chinnery and Hudson, 2013) (Figure 1-3B). The only large non-coding 
region in the mammalian mtDNA is the named non-coding control region (NCR) and is 
∼1.1 kb of size in human mtDNA (Nicholls and Minczuk, 2014). However, the non-coding 
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control region (NCR) (See Figure 1-3A and chapter 1.2.2) contains several important 
regulatory sequences: (1) promoters for transcription of light and heavy strands, (2) the 
replication origin of the heavy strand, (3) the regulatory conserved sequence blocks (CSB 
1-3), (4) the termination-associated sequence TAS, and (5) the displacement loop (D-loop) 
structure (Nicholls and Minczuk, 2014). 
 
 
Figure 1-3. Mammalian mitochondrial DNA. A) Schematic representation of the non-coding region 
(NCR) area. This area contains the LSP (light strand promoter) and HSP (heavy strand promoter), the 
conserved sequence blocks (CSB1, CSB2, CSB3), the origin of replication of the heavy strand (OH) and 
the termination-associated sequences (TAS). In this area, the displacement loop (D-loop) is formed by 
the replication of the 7S DNA. B) Annotated genetic features of the mtDNA molecule. Here is shown 
the heavy-strand encoding majority of genes and also the light strand, which only encodes for ND6 and 
8 tRNAs. Genes are coloured by type of gene-encoded. Figure modified from Nicholls and Minczuk, 
2014. License Number 4737910785177 by Elsevier and Copyright Clearance Center.  
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?????? ??????????????????????????????????????????????????
MtDNA is tightly packed in structures named nucleoids. These structures have an 
ellipsoidal shape, with a diameter of ∼100nm, and on average	 contain	 1.4 copies of 
mtDNA per nucleoid. In this regard, mitochondrial transcription factor A (TFAM) of 
mammals has been identified as the basic and minimum component for the compaction of 
these structures. In detail, TFAM has been proved not only to be abundant in the mtDNA 
(∼1000 molecules of TFAM per mtDNA molecule) but also to be capable of bending 
mtDNA (even 180°) (Bonekamp and Larsson, 2018; Kukat et al., 2011, 2015). Additionally, 
TFAM has been demonstrated to regulate mtDNA copy number (Ekstrand et al., 2004; 
Farge et al., 2014).  
The mtDNA exhibits exceptional characteristics. For instance, unlike in the nucleus, the 
codon code used by the mitochondria involves a minimalistic set of tRNAs.  In humans, for 
example, the tRNAMet in the nucleus only recognises AUG codons but in mitochondria binds 
also AUA codons (and AUU for the start codon of the NADH dehydrogenase subunit 2). In 
the case of the isoleucine, only one single species of tRNAIle is necessary to translate both 
isoleucine codons (Boos et al., 2016; Chinnery and Hudson, 2013). A remarkable feature of 
the mitochondrial genome is the multi-copy nature of it. It has been estimated that each 
mitochondrion can contain ∼1-3 molecules of mtDNA (Wiesner et al., 1992). However, 
mitochondria are dynamic organelles and during fusion and fission processes, mitochondria 
can exchange mtDNA (Arimura et al., 2004). Therefore, a more reliable quantification is to 
use mtDNA copy number per cell. In that regard, each nucleated cell (excluding the 
germline) can contain between 100 and 10,000 copies depending on the cell type. For 
example, in humans, leukocytes contain ∼350 (Liou et al., 2010), while myocardial cells 
contain ∼6,000 copies per cell (Miller, 2003). Although the mechanisms regulating copy 
number are still not fully understood, one of the mechanisms to maintain and regulate 
mtDNA copy number is mtDNA replication (Shadel and Horvath, 2015).  
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1.3. mtDNA replication  
?????? ???????????
In vitro studies suggest that in mammals, the minimum machinery necessary for mtDNA 
replication consists of three proteins: single-stranded DNA binding protein (mtSSB), 
TWINKLE, and the core of the machinery, the mitochondrial DNA polymerase gamma (Pol 
γ). In this complex, normally named the replisome, the Pol γ is incapable of using annealed, 
double-stranded DNA (dsDNA) as a template. Therefore, it is required that the helicase 
TWINKLE unwinds the mtDNA and leads to the exposure of single-stranded DNA. The 
single-stranded binding protein mtSSB is also involved in stimulating this reaction and then 
binds to the displaced single-stranded DNA (Korhonen et al., 2004). However, in vivo, other 
proteins may also play an important role like mitochondrial genome maintenance 
exonuclease 1 (MGME1) that processes the 5’ ends, enabling efficient ligation of newly 
replicated mtDNA (Uhler et al., 2016), or the ribonuclease H1 (RNaseH1), that removes the 
RNA primer used for initiating replication (Cerritelli et al., 2003).  
 
 
?????? ???????????? ?????
Mitochondrial replication research studies dates back to 1981 (Anderson et al., 1981); 
however, the exact replication mechanism is still under investigation and many models 
remain controversial. In the literature, three replication models have been proposed: (1) the 
strand displacement model (SDM) (Brown et al., 2005; Clayton, 1982, 2000; Shadel and 
Clayton, 1997), (2) the strand-coupled model (Holt et al., 2007), and (3) the mtDNA 
replication model via ribonucleotide incorporation throughout the lagging strand (RITOLS) 
(Yasukawa et al., 2006).  
To date, the model with major experimental support is the strand displacement model 
(SDM), which through the years has been improved. According to this model, DNA 
synthesis occurs in both strands (each strand with their own replication origin) but 
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replication of the strands does not start at the same time (Gustafsson et al., 2016). According 
to the SDM, mtDNA replication initiates with the synthesis of a primer at the OH (heavy 
strand origin), probably by POLRMT (mitochondrial RNA polymerase) (Fusté et al., 2010). 
Then, Pol γ begins the DNA synthesis with TWINKLE unwinding the DNA. During this 
first step of the synthesis, the L-strand acts as a template, and the H-strand is displaced and 
coated with mtSSB proteins. mtSSB proteins. The latter not only cover the displaced strand, 
but they also help to block transcription by preventing random initiation of RNA primer 
synthesis (Gammage and Frezza, 2019).   
 
 
Figure 1-4. Strand-displacement mtDNA replication model.  Replication initiates with the synthesis 
of a RNA primer by POLRMT, then Pol  begins the DNA synthesis, with TWINKLE unwinding the 
DNA. The L-strand acts as a template; the H-strand is displaced and coated with mtSSB proteins. When 
replication reaches OL, a stem-loop is formed. The stem-loop allows the creation of an RNA primer by 
POLRMT, which starts the synthesis of the L-strand using the H-strand as a template. When DNA 
synthesis is completed, hemicatenated DNA is resolved by the topoisomerase 3a. In the end, the 
RNaseH1 and FEN1 remove the RNA primers. Figure from Gammage and Frezza, 2019. Figure license 
under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/). 
 
When the replication machinery reaches OL (light strand origin), which is about two-thirds 
of the way around the mtDNA molecule, a stem-loop is formed. This structure avoids the 
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binding of mtSSB proteins, allowing POLRMT to initiate the synthesis of ∼25 nucleotides 
of an RNA primer. Then, POLRMT is replaced by Pol γ; and the synthesis of the new L-
strand begins in the opposite direction, using the H-strand as a template (Gammage and 
Frezza, 2019; Gustafsson et al., 2016). When mtDNA synthesis is completed, 
hemicatenated DNA is resolved by the topoisomerase 3α (TOP3α) (Nicholls et al., 2018), 
and the RNA primers are removed, most likely by RNaseH1 or MGME1 (Uhler and 
Falkenberg, 2015).  
 
 
?????? ???????
Previous studies indicate that more than 95% of all replication events are prematurely 
terminated (Bogenhagen and Clayton, 1978). This produces a small DNA product of ~650 
nucleotides named 7S DNA. The 7S DNA fragment starts to be synthesized around the 
origin OH until the termination associated sequences (TAS). The short 7S DNA fragment 
remains bound to the parental L-strand, forming in the NCR a D-loop shape structure (triple-
stranded structure) (Figure 1-3A) (Falkenberg, 2018).  
In mammals, the proportion of mtDNA molecules with D-loop is variable. For instance, 
depending on the tissue, it can range from 1% to 82% (Nicholls and Minczuk, 2014). It has 
been proposed that the D-loop is important for the regulation of mtDNA replication and 
mtDNA maintenance. For example,  it has been suggested that it is a binding centre for 
proteins that regulate mitochondrial nucleoids dynamics, such as Pol γ or TWINKLE (He 
et al., 2007; Jemt et al., 2015). However, the precise function and regulating mechanisms at 
the D-loop have not been elucidated yet (Nicholls and Minczuk 2014). 
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1.4. Mitochondrial polymerase 
?????? ??????????????????????????????????????????????
All proteins required for mtDNA replication are encoded by nuclear DNA, including the 
Pol γ (polymerase gamma), the key protein for replication (Capps et al., 2003). From the 16 
polymerases in mammals, only the Pol γ has demonstrated to be responsible for the mtDNA 
synthesis and proofreading. More specifically, several studies confirm that Pol γ is localised 
in the mitochondria  (Krasich and Copeland, 2017), and Pol γ is the only mitochondrial 
DNA polymerase demonstrated to be embryonically lethal when it is depleted (Hance et al., 
2005). Moreover, mutations in this protein have shown to increase mtDNA mutations (Chan 
and Copeland, 2009).  The Pol γ holoenzyme is a heterotrimeric protein composed of one 
catalytic subunit POLG and two accessory subunits POLGB (Graziewicz et al., 2006). In 
mammals, the catalytic subunit POLG (alternative symbols: Pol γA, POLG1 or POLGA) of 
∼140 kDa, is encoded by the Polg gene (or Polg1). In humans, the gene localises in 
chromosome 15 (current reference NC_000015.10) while in mice it localises in 
chromosome 7 (current reference NC_000073.6). The catalytic subunit has three main 
functions: DNA polymerase, 3’-5’ exonuclease and 5’ dRP lyase activity. Each function is 
encoded in a specific domain (Figure 1-5) (Graziewicz et al., 2006); and sequence alignment 
has revealed that the DNA polymerase and the 3’-5’ exonuclease domains are well 
conserved across species (Ito and Braithwaite, 1991). 
The accessory subunit POLGB (alternative symbols: Pol γB or POLG2) of ∼55 kDa, 
encoded by the Polg2 gene, is also important. POLGB increases the processivity of the 
enzyme almost100-fold  because it increases the enzyme affinity for the template DNA 
(Carrodeguas et al., 2002; Lim et al., 1999) and also, it has been suggested, because 
suppresses the exonuclease activity (Graziewicz et al., 2006).   
In 2009, the crystal structure and modelling of the human Pol γ showed that the POLG 
catalytic subunit is closely related to the polymerase from the bacteriophage T7, and adopts 
a canonical “right-hand” configuration. In this configuration, a positively charged channel 
formed by the thumb, palm, and fingers of the POLG surrounds the mtDNA. Because the 
POLG spacer domain (between the pol and exo domains) interacts only with one POLB 
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monomer, it has been proposed that the DNA-binding affinity is specific of the catalytic 
subunit POLG (Lee et al., 2009). 
 
 
Figure 1-5. Scheme of the conserved domains in the catalytic subunit POLG. In red, the 3’-5’ 
exonuclease domains encoded by I, II and III motifs. In blue, the polymerase domain, encoded by the 
A, B and C motifs. In yellow, the conserved sequences in vertebrates (weakly conserved in insects). To 
the right, the number of amino acids predicted for the PolG protein of some species. Figure from 
Graziewicz 2006. Figure not subject of U.S. Copyright but adapted from Kaguni 2004. 
 
 
?????? ???????????????????????
The catalytic subunit POLG is part of the A polymerases family, had a broad pH range (7.5-
8) and requires a divalent metal cation (Mg2+ cations are preferred when processing DNA 
templates) (Kaguni, 2004). 
POLG contains several functions, for example, the 5’ dRP lyase activity. This function 
removes the 5’-terminal dRP sugar moiety generated by glycosylases and AP endonucleases 
during DNA damage repair (therefore important for the base-excision repair in 
mitochondria) (Kaguni, 2004). Additionally, in vitro studies showed that Pol γ also possess 
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a reverse transcriptase activity and other catalytic RNA-associated activities (Murakami et 
al., 2003). POLG has also been recently implicated in the degradation of linearized mtDNA 
(Nissanka et al., 2018; Peeva et al., 2018).  
However, the major function of POLG is during replication. POLG displays accurate 
polymerisation (Lee and Johnson, 2006; Lynch, 2011) on the one hand by discriminating 
the correct nucleotides and on the other hand by correcting the errors with the 3’-5’ 
exonuclease activity.  So, the overall fidelity is the result of the sum of both reactions 
(Johnson and Johnson, 2001).  Polymerase selectivity is complex, as each polymerase needs 
to select the correct one from a pool of four similar desoxynucleotide triphosphates (dNTPs) 
to pair in a Watson-Crick base manner. Additionally, the identity of the correct dNTP 
changes with each step along the template strand (Showalter and Tsai, 2002). However, the 
exonuclease activity can increase the fidelity from 5-34 fold depending on the substrate and 
the mis-pair (Kaguni, 2004) and despite being a complex reaction, it seems not to be 
significantly affected by the polymerisation process (Johnson and Johnson, 2001).  
 
 
?????? ???????????????????????
Currently, ~180 unique disease-causing point mutations in the gene encoding the catalytic 
subunit POLG have been reported in humans. These mutations have been associated with a 
number of different diseases (Figure 1-6, Human DNA Polymerase Gamma Mutation Data 
Base: https://tools.niehs.nih.gov/polg/) (Nurminen et al., 2017) like Progressive External 
Ophthalmoplegia (PEO), Alpers-Huttenlocher syndrome (AHS), childhood 
myocerebrohepatopathyspectrum (MCHS), myoclonic epilepsymyopathy sensory ataxia 
(MEMSA) and Ataxia neuropathy spectrum (ANS) (Chan and Copeland, 2009). 
Symptoms usually appear in compound heterozygous patients bearing two distinct recessive 
alleles,  or in autosomal dominant syndromes (Nurminen et al., 2017). In general, symptoms 
can be variable like, epilepsy, myopathy, ataxia; and the time when the symptoms appear is 
very variable, from early neonatal to middle age. Therefore, the clinical identification of 
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POLG-related disorders includes the combination of symptoms, different tempos of disease 
progression, affected organs, neurological signs, and the sudden appearance of symptoms 
during stressful illnesses (like a viral infection) (Cohen and Naviaux, 2010). For example, 
PEO is a mitochondrial disorder transmitted mainly in an autosomal dominant way, but 
autosomal recessive alleles are also known). The disorder is characterised by progressive 
weakness of the external eye muscle responsible for eye movements, exercise intolerance, 
hearing loss, hypogonadism, dysphagia, and,  neuromuscular problems. Symptoms often 
appear when the patient is between 18 and 48 years old.  Another example is Alpers 
syndrome, characterised by progressive spastic quadriplegia, with progressive cerebral 
degeneration, cortical blindness, deafness and early death. In this case, the disorder is an 
autosomal recessive disease, affecting children of only a few years old (Chan and Copeland, 
2009; Graziewicz et al., 2006).   
According to the crystal structure, Lee et al. propose that depending on the domain where 
the mutations are located, they can affect either the catalytic enzyme activity (like 
polymerase activity, exonuclease activity or dRP lyase activity), alter the affinity for the 
mtDNA or disrupt the interaction with the accessory subunits and decrease the processivity 
(Lee et al., 2009). For instance, substitutions in the polymerase domain like H932Y, R943H 
and Y955C, which have been related to PEO disorders, show that mutant POLG’s have a 
severe polymerase activity reduction in in vitro assays (Graziewicz et al., 2006; Stumpf et 
al., 2010). Moreover, in vitro, Y955C POLG mutant cells are 2-fold less accurate for base 
pair substitutions and can even increase 10-100 fold when exonuclease activity is 
inactivated (Ponamarev et al., 2002).  
The identification of mutations associated to the POLG exonuclease domain could lead to 
the idea that these mutations generate a mutator phenotype, due to a deficient proof reading 
activity. Surprisingly, to date, mutations in the exonuclease domain of the POLG that have 
been found in humans, do not cause a mitochondrial mutator phenotype in vivo nor in vitro 
(Baruffini et al., 2006; Stumpf et al., 2010; Szczepanowska and Foury, 2010). On the 
contrary, mutations in the exonuclease domain seem to increase the activity generating a 
severe imbalance between mtDNA polymerisation and degradation (Szczepanowska and 
Foury, 2010). It is unknown if some exonuclease-deficient POLG variants exist within the 
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healthy populations. However, a mutator phenotype is not a clinical factor displayed in 
POLG-related disorders (Stumpf et al., 2013). 
 
 
Figure 1-6. Human mutations reported to be associated to diseases. The figure shows the reported 
mutations in the POLG gene associated with different diseases until 20.02.2019. Figure from the 
National Institute of Environmental Health Sciences, https://tools.niehs.nih.gov/polg/. Rights from 
Copeland PhD.  
 
POLG point mutations have not only been associated with disorders but also repeated 
sequences and pathogenic variants. For instance, in humans, near the N-terminus of the 
POLG gene, there is a CAG(n) repeat sequence encoding 13 glutamine residues (Figure 1-
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6). These POLG gene CAG repeat variants have been linked to idiopathic sporadic 
Parkinson's disease (Luoma et al., 2007), risk of testicular cancer (Nowak et al., 2005) and 
male infertility (Rovio et al., 2001).  In addition, POLG pathogenic variants have been 
associated with MNGIE-like illness (Tang et al., 2012) and Charcot-Marie-Tooth 
neuropathy type 2 (Harrower et al., 2008; Naess et al., 2009; Taanman et al., 2009).  
 
 
1.5. Mitochondrial POLG mutator mouse model 
?????? ???????? ??? ?????????????? ????? ???????? ??????
???????
Studies of model organism engineered with mitochondrial polymerase mutations date back 
to 1992 when several mutations where introduced in the gene MIP1 that codes for the 
mitochondrial DNA polymerase of yeast (Foury and Vanderstraeten, 1992). Results from 
those studies concluded that specific mutations in the exo1, exo2, and exo3 of MIP1 reduce 
the fidelity of replication by reducing the exonuclease activity (Foury and Vanderstraeten, 
1992; Vanderstraeten et al., 1998).  To date, several transgenic mice with variants in the 
POLG gene have been constructed. Of those, the majority of mutant mice contain a deficient 
proofreading exonuclease. There is only one reported mouse model with a POLG 
ectopically expressed mutation in the polymerase domain. This mouse carries a POLG 
Y955C point mutation, targeted at the heart, and resembles the same mutation that causes 
PEO (progressive external ophthalmoplegia). The mice displayed cardiomyopathy, with 
signs of oxidative stress and premature death (Lewis et al., 2007). 
In 2000, Kasahara and colleagues constructed a transgenic mouse with the ectopic 
expression of a POLG mutant (D181A), under a mouse cardiac-specific α-myosin heavy 
chain (α-MHC) promoter. This mouse displays signs of cardiomyopathy with no apparent 
deleterious effects on mitochondrial protein content, gene expression or respiratory 
functions. This model also showed mtDNA mutations and deletions (Zhang et al., 2000).  
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Another mouse with the same D181A proofreading-deficient POLG expressed ectopically, 
but neuronal-specific targeted under the promoter of mouse Ca2+/calmodulin-activated 
protein kinase II α (CaMKIIα), was published in 2006. This mouse exhibited forebrain-
specific defects in mtDNA. As the main phenotype, the mouse displays altered intra-day 
wheel-running activity rhythm without any detectable abnormalities in sensorimotor 
functions, like learning or memory (Kasahara et al., 2006).  
A breakthrough occurred when two independent research groups (Larsson and Prolla 
groups) created a constitutive knock-in mouse (D257A) with a disrupted POLG 
proofreading function. These mice, named mtDNA mutator mice, display a remarkable 
characteristic: they recapitulate several signs of premature ageing (Kujoth et al., 2005; 
Trifunovic et al., 2004). To date, the mutator mouse is the most studied POLG mutant mouse 
model.  
 
 
?????? ????????????? ?????????????????? ??????? ????
The knock-in mitochondrial mutator mouse carries a missense mutation with a single 
aspartate mutated to alanine in the residue 257 (D257A).  This mutation, in the exonuclease 
domain of POLG, drastically reduce the 3’-5’ proof-reading activity of the polymerase. As 
a result, the homozygous mutator mouse shows high levels of point mutations, reaching 20-
30 mutations per molecule of mtDNA (Ross et al., 2013).  
The literature also indicates that mtDNA mutator mice show an increased amount of unusual 
linearised mtDNA deletions. It has been reported that the homozygous mutator mouse 
displays an increased amount of linear mtDNA deletions (25-30% of mtDNA), 
encompassing the region between the origins of replication OH and OL (Trifunovic et al., 
2004). These deletions are possibly the result of impaired ligation, which cause nicks near 
to the replication origin of the heavy strand. These nicks generate that during the subsequent 
round of replication, linear fragments form due to double-strand breaks (Macao et al., 2015). 
Additionally, the accumulation of circular mtDNA molecules with large deletions have been 
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reported whereas, some authors have not detected these type of deletions (Ameur et al., 
2011; Williams et al., 2010), others estimate, that from the total mtDNA only ~1% or fewer 
molecules contain large deletions (Kraytsberg et al., 2009; Vermulst et al., 2008). Finally, 
it has also been found, that mutator mice accumulate control region multimers (CRMs) in 
the brain, heart and skeletal muscle. These CRMs are repeated sequences around the 5’ end 
of the mtDNA control region (Williams et al., 2010). 
At the biochemical level, the homozygous mutator mouse cells shows decreased oxygen 
consumption, reduction in ATP content (Trifunovic et al., 2005) and severely impaired 
stability of the respiratory chain complexes (Edgar et al., 2009).  Consequently, the mutator 
mouse displays mitochondrial dysfunction which has been proposed as the primary inducer 
of the premature aging phenotype (Edgar and Trifunovic, 2009). Additionally, this mouse 
model has shown no increased level of ROS (Hiona and Leeuwenburgh, 2008; Kujoth, 
2007; Trifunovic et al., 2005), which argues against the role of oxidative stress as an 
inductor of aging in the mouse model (Alexeyev, 2009). 
To date, three mtDNA mutator mouse strains with the same D257A mutation have been 
described in the literature. In 2004, Larsson and colleagues (Trifunovic et al., 2004) 
generated the first D257A mutator mouse and have maintained it on the C57BL/6NCrl 
mouse substrain. They observed premature ageing-related phenotypes such as weight loss, 
alopecia, kyphosis (curvature of the spine), reduced subcutaneous fat, osteoporosis, 
anaemia, reduced fertility, reduced testis size, heart enlargement and drastically reduced life 
span. To generate the mutation, they used a FLP-FRT recombination system to produce a 
change at the position 257 from an aspartic acid (GAC) to an alanine (GCC). In detail, for 
the construct, the PolgA gene clone derive from the 129/SvJ l Fix II phage library 
(Stratagene). This construct was used for targeting knock-in 129/SvJ embryonic stem cells, 
which were introduced into blastocyst to create chimeric mice that transmitted the target 
mutation. The line was subsequently maintained on the C57Bl/6NCrl substrain. As a result 
of the methodology used, the final allele maintains two loxP sites flanking the mutation, and 
one Frt site upstream of it. 
In 2005, Prolla and colleagues (Kujoth et al., 2005) generated a second D257A mutator 
mouse and maintained it on the C57BL/6J mouse substrain (Kujoth, 2007). They observed 
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the same premature age-related phenotypes than previously reported by Larsson’s group, in 
addition to presbycusis (hearing loss), sarcopenia, thymic involution and loss of duodenum 
crypts. In the report (Kujoth, 2007), they also showed the induction of apoptotic markers. 
To generate the mutation, they used a Cre-lox recombination system to generate a change 
at the position 257 from an aspartic acid (GAC) to an alanine (GCT). Genomic manipulation 
was carried out on a clone from the same 129/SvJ l Fix II phage library (Stratagene), and 
the manipulated construct was also introduced into 129Sv ES cells.  The final allele contains 
a loxP site downstream of the D257A mutation.  In 2013, Hayashi and colleagues (Mito et 
al., 2013) published a third D257A mutator generated in the C57BL/6NCrl substrain 
showing the same premature ageing phenotype. In this report, they used the same 
methodology as in Trifunovic et al. to generate the mutation (Mito et al., 2013). 
The three mutator mouse models show the same premature ageing phenotype but they differ 
in time of symptoms onset. Larsson and colleagues reported that symptoms in the 
homozygous mutator start to appear at 25 weeks (Trifunovic et al., 2004). In comparison, 
Prolla and colleagues reported the beginning of symptoms at 36 weeks (Kujoth et al., 2005). 
Moreover, the lifespan reported it is variable. Initial research with the mutator mice from 
Larsson laboratory have reported a median lifespan of 48 weeks (Trifunovic et al., 2004); 
in contrast, reports from Prolla and colleagues reported a median lifespan of 60 weeks 
(Kujoth et al., 2005) and 65 weeks (Someya et al., 2017) for the homozygous mutator.  
It is not yet known if the differences in lifespan and the onset of the phenotype are due to 
variation of the genetic background (C57BL/6J and  C57BL/6NCrl), or if such differences 
are due to the specific allele used for each mutator mice. Even so, these studies do not take 
into account the details of the breeding. In 2013, Ross et al. reported that maternally 
transmitted mutations can reduce lifespan. Taking as a reference the mutator mice from 
Larsson research group, they determined that the standard breeding (with low level 
maternally transmitted mutations) show a median lifespan of 42 weeks, but using a breeding 
scheme which avoids maternally transmitted mutations, the lifespan can increase up to 50 
weeks. Therefore, it has been difficult to compare previous reports side by side.  
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?????? ???????? ??????????????????? ?????
Ageing is a process of fitness decline observed over time (Kauppila et al., 2017). Although 
ageing is more evident among humans and animals maintained in captivity, a large number 
of studies have shown that the majority of metazoans in the wild show signs of ageing 
(Kauppila et al., 2017; Nussey et al., 2013). The main cause of ageing is unknown, however, 
a number of hallmarks that could contribute to the ageing process are: (1) genomic 
instability, (2) telomerase attrition, (3) epigenetic alterations, (4) loss of proteostasis, (5) 
deregulated nutrient sensing, (6) altered intracellular communication, (7) cellular 
senescence, (8) stem cell exhaustion and (9) mitochondrial dysfunction (López-Otín et al., 
2013).  
Alterations of mitochondrial function as important players in the ageing process are well 
documented in the literature (Haas, 2019). For instance, mitochondrial dysfunction has been 
widely related to the aging of the immune system (McGuire, 2019), skin ageing (Stout and 
Birch-Machin, 2019), and ageing-related illnesses like cardiomyopathies (Duran et al., 
2019), diabetes (Montgomery, 2019), Parkinson (Chen et al., 2019) and Alzheimer disease 
(Weidling and Swerdlow, 2019). Mutations of mtDNA are hypothesised to cause 
mitochondrial dysfunction in ageing (Kauppila et al., 2017). Since ∼93% of the 
mitochondrial genome encodes important mitochondrial genes (Andrews et al., 1999; 
Kolesnikov and Gerasimov, 2012), the probability that random mtDNA mutations alters an 
important sequence is high. Mutations will then be clonally expanded during the years 
(Elson et al., 2001; Greaves et al., 2012; Wanrooij et al., 2012) leading to mitochondrial 
dysfunction (Edgar et al., 2009).  Moreover, evidence that supports this theory is that ageing 
in humans has been associated with an increase of mtDNA deletions and point mutations.  
During ageing in post-mitotic tissues the predominant mtDNA mutations are large-scale 
mtDNA deletions (Cortopassi and Arnheim, 1990; Cortopassi et al., 1992; Kraytsberg et 
al., 2006), and in mitotic tissues mtDNA point mutations are more commonly identified 
(Greaves et al., 2006, 2010; Shin et al., 2004). In addition, maternally transmitted mtDNA 
mutations can reduce lifespan in animals with a wild-type nuclear background (Ross et al., 
2014). However, it is unknown if these mtDNA mutations are the cause or a consequence 
of ageing (Payne and Chinnery, 2015).  
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In that regard, the mutator mouse model supports the hypothesis that mtDNA mutations 
could be implicated in ageing, as the mouse exhibit a premature progeria phenotype that 
resembles in some extent human clinic symptoms of ageing and display mitochondrial 
dysfunction with increased number of point mutations and deletions (Kujoth et al., 2005; 
Trifunovic et al., 2004). Evidence that supports the hypothesis that mtDNA point mutations 
are the driving force of the ageing phenotype in the mutator mouse is that the accumulation 
of mtDNA point mutations impairs the stability of the respiratory complexes, by amino acid 
substitutions leading to mitochondrial dysfunction (Edgar et al., 2009).  In addition, it has 
been demonstrated that patterns of clonally expanded mtDNA mutations in colons of 
heterozygous mutator mice, resemble the patterns exhibited in ageing humans (Baines et 
al., 2014).  
However, ageing research using the mutator mouse as an ageing model should be interpreted 
with caution. Like any other mouse model of ageing, the mutator mouse phenotype does not 
fully represent normal ageing and the mechanisms of premature ageing could be different 
from the normal ageing process (Kõks et al., 2016). For example, mtDNA deletions found 
in the mutator mouse and in humans are different. Most of the mtDNA deletions that are 
found during normal ageing affect the major arc of mtDNA (Dong 2014, Samuels 2004) 
and are classified into two types. Type I, deletions flanked by homologous or near-
homologous repeats; and type II, deletions not flanked by homologous repeats and co-
localised in secondary DNA structures like hairpins, or G-quadruplex structures (Damas 
2012 and Dong 2014).  In contrast, the majority of mtDNA deletions in the mutator mouse 
affect the minor arc, and in some tissues has been described low levels of deletions between 
homologous sequences (Kraytsberg et al., 2009; Vermulst et al., 2008). In addition, in a 
recent publication, Hämäläinen et al. show that errors during mtDNA replication in the 
mutator mouse might induce nuclear DNA replication stress. In the publication, they show 
evidence that in mutator mouse induced pluripotent stem cells (iPSC) there is increased 
replication stress and DNA damage in the nucleus.  They also show that the dNTP 
sequestering generated in the mitochondria leads to an imbalance in the dNTP pools used 
for the nucleus (Hämäläinen et al., 2019).   
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The mtDNA mutator mouse model has been used to study not only the effects of a deficient 
exonuclease POLG on mtDNA mutations and ageing; but also to decipher the molecular 
mechanisms of the distribution and transmission of mtDNA mutations (Stewart and 
Chinnery, 2015; Stewart and Larsson, 2014; Stewart et al., 2008). Moreover, the mutator 
mouse has been proved to be an essential tool to generate novel mouse models that carry 
pathogenic mtDNA mutations which are important for the study of mitochondrial diseases 
(Kauppila et al., 2016). 
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2. RESEARCH AIMS 
The first mtDNA mutator mouse was generated almost 16 years ago (Trifunovic et al., 
2004). Since that moment, it has become a powerful tool to study and investigate mtDNA 
mutations in general, and mtDNA mutations in one of the most intriguing scientific topics: 
ageing.  
This mutator mouse model carries an altered mtDNA polymerase with a mutation in the 
exonuclease domain that results in increased mtDNA mutations and, additionally, 
recapitulates several signs of premature ageing. To date, three mtDNA mutator mouse 
strains with the same D257A mutation have been described in the literature. In general 
terms, the first mutator mouse was maintained in the C57BL/6NCrl mouse substrain, in the 
Larsson research group (Trifunovic et al., 2004). One year later, using another 
recombination strategy to generate the mutation, the Prolla research group published a 
second mutator mouse, which was maintained in the C57BL/6J mouse substrain (Kujoth et 
al., 2005). The reports showed that both mutator mouse models contain the same D257A 
POLG mutation but with genetically allele variations in non-coding sequences. Recently, a 
third mutator was generated in the C57BL/6J substrain with a POLG allele like the one 
described by Larsson research group (Mito et al., 2013).  
Interestingly, all of them show a similar premature ageing phenotype. However, they differ 
drastically in the time when the symptoms appear and, even more remarkable, exhibit 
striking differences regarding lifespan. For instance, mutator mice reported by Trifunovic 
et al., (2004) and Mito et al., (2013), showed a median lifespan of 48 and 40 weeks 
respectively, while the mutator reported by Kujoth et al., (2005), shows a higher median 
lifespan of 59 weeks. In addition, there was a reported 11 weeks difference in the onset of 
symptoms between Trifunovic et al., (2004) and Kujoth et al., (2005) (25 weeks vs 36 
weeks). 
Therefore, the aim of my Ph.D. project was: 
1)  By evaluating and characterising different mutator mouse lines, determine if previously 
reported variations among the mtDNA mutator mouse models were because of: 
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a) Differences in the genetic background 
b) Differences in the allele expressed 
2)  Investigate the molecular mechanisms responsible for the phenotypical variation 
between the mtDNA mutator mouse models. 
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3. RESULTS 
3.1. Description, generation, and maintenance of 
mtDNA mutator mouse lines. 
To date, three mtDNA mutator mouse strains with the same D257A mutation have been 
described in the literature by independent groups using two different recombinant mutation 
strategies and two different mice sub-strains to maintain the mice lines (Kujoth et al., 2005; 
Mito et al., 2013; Trifunovic et al., 2004). However, the reports showed a drastic variation 
in lifespan and in the time when the symptoms appear.  
Therefore, in order to determine the reasons behind the progeria variation rate among the 
previously reported mtDNA mutator mouse models, we decided to evaluate two hypotheses 
1) Differences are due to the mouse substrain used and 2) Differences are due to the allele 
expressed. To test our ideas, we used a series of mtDNA mutant mouse lines that allowed 
us to discriminate between these two hypotheses (Table 3-1). 
In-house, we had access to the original mtDNA mutator mice from Trifunovic et al., (2004), 
that in this study we name B6NPolgLar/Lar. This mouse line contains the D257A mutation, 
labelled here as Lar allele, maintained in the C57BL/6NCrl substrain.  
To test our first hypothesis, we wanted to compare mutators with different genetic 
backgrounds but same allele. Therefore, we generated a new mouse line, named here 
B6JPolgLar/Lar, which allowed us to compare the allele Lar but in the C57BL/6J background. 
To generate the B6JPolgLar/Lar mouse line, we backcrossed B6NPolgwt/Lar males with 
C57BL/6J wild-type females. Selecting from the offspring heterozygous males 
B6JNPolgwt/Lar and backcrossing them with C57BL/6J wild-type females for more than 10 
generations, we were able to obtain heterozygous B6JPolgwt/Lar mice with 99.99% 
C57BL/6J genetic background. These heterozygous B6JPolgwt/Lar mice were mated to obtain 
homozygous B6JPolgLar/Lar mice (Figure 3-1). 
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Table 3-1. Mouse lines used in this study. The table summarises the characteristics of the mouse lines 
and the colour code used in the graphs of this study. 
 
To test our second hypothesis, we wanted to compare mutators with the same genetic 
background but different alleles. Therefore, from Jackson Laboratories, we purchased the 
original mutator mice published by Kujoth et al., (2005). In this study, we name this mouse 
B6JPolgPro/Pro. This mouse contains the D257A mutation, labelled here Pro allele, 
maintained in the C57BL/6J substrain. Comparing this new line B6JPolgPro/Pro with the 
previously generated B6JPolgLar/Lar, allowed us to analyse different alleles (Lar and Pro) at 
the same genetic background (C57BL/6J) (See Table 3-1). We did not analyse the allele 
generated by Mito et al., (2013) due to a lack of access to the mouse. 
It is important to note that we always used a breeding scheme lacking maternally transmitted 
mtDNA mutations, previously described by Ross et al., (2013). In this scheme, the mutation 
D257A was maintained in heterozygous males, in order to avoid mtDNA mutations 
inherited maternally by germline transmission. 
During this study, we also analysed a compound heterozygous mutator mouse B6JPolgLar/Pro 
for splicing analysis, and two hemizygous mutant lines B6JPolgLar/ko and B6JPolgPro/ko for 
mtDNA sequencing. The complete list with characteristics of each line can be found in 
Table 3-1.  
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Figure 3-1. Breeding strategy to generate the B6JPolgLar/Lar. A male heterozygous Lar mutant was 
backcrossed with wild-type females C57BL/6J for more than 10 generations, as a result, a heterozygous 
Lar mutant was obtained with 99.9% C57BL6J genetic background. Finally, homozygous mutants were 
obtained crossing two heterozygous mutants. 
 
 
3.2. Increased Cardiomyopathy and Anaemia in 
mice with the Lar allele. 
Studies have reported that mutations and deletions in the mtDNA can lead to impairment of 
mitochondria, causing tissue dysfunction (reviewed in Bates et al., 2012; Bratic and 
Larsson, 2013; Kauppila et al., 2017).  
The heart for example, an organ rich in mitochondria, is assumed to be very sensitive to 
mitochondrial dysfunction due to its high oxygen consumption rate (Dai et al., 2010). In 
addition, it has been demonstrated that mutations in the mtDNA have a big impact on the 
cardiac progenitor cell differentiation function (Orogo et al., 2015). Interestingly, 
cardiomyopathy is one of the best-characterised phenotypes in the mtDNA mutator mouse 
(Dai et al., 2010; Orogo et al., 2015; Safdar et al., 2011; Trifunovic et al., 2004; Woodall 
et al., 2019). Therefore, to investigate whether there is a difference in cardiomyopathy 
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between these three different mutator mouse lines (Table 3-1), we screened for heart 
enlargement, which is a marker of heart disease.  
When we analysed the weight of the heart in relation to the body of mutators at 10 weeks 
old, we did not find a difference in comparison with wild-type animals. However, at 35 
weeks old, when the ageing phenotype is evident in the mutator, the data showed a heart 
enlargement in the three mutator mouse lines compared to wild-type animals. The 
B6NPolgLar/Lar mouse displayed the greatest enlargement, followed by the B6JPolgLar/Lar 
mouse, and the B6JPolgPro/Pro mouse with the least amount of enlargement (Figure 3-1A). 
Another well-characterised phenotype in the mtDNA mutator mouse, which is caused by 
the impairment of mitochondria function, is anaemia (Reviewed by  Ahlqvist et al., 2015). 
Actually, severe anaemia has been described as the main cause of death in the mutator 
mouse and data suggested it is due to a dysfunctional repopulation of haematopoietic stem 
cells, myeloid differentiation problems and defective mitophagy during erythrocyte 
maturation (Ahlqvist, 2015; Ahlqvist et al., 2012; Chen et al., 2009; Norddahl et al., 2011).  
Anaemia is defined as a reduction in haemoglobin, haematocrit or red blood cell count. 
Therefore, we performed blood cell count of erythrocytes and measured haemoglobin 
concentration in 35 week-old mice. Our data showed, as was previously reported (Dillon et 
al., 2012; Trifunovic et al., 2004), that mutator mice contain significantly lower 
haemoglobin and erythrocyte concentrations in peripheral blood, when compared to wild-
type mice. Notably, we saw only a mild decrease in B6JPolgPro/Pro (22% reduction) and a 
strong decrease in mutator mice with Lar allele (B6NPolgLar/Lar and B6JPolgLar/Lar) (more 
than 40% reduction) (Figure 3-2C).  
Previously, anaemia in the mutator mouse has been described as macrocytic with increased 
red pulp (Trifunovic et al., 2004), two characteristics that can lead to spleen enlargement 
(splenomegaly) (Pivkin et al., 2016). Therefore, we analysed the ratio of spleen weight to 
body weight in 35-week-old mice. Strikingly, B6JPolgPro/Pro weight was not altered in 
comparison with wild-type animals, but B6NPolgLar/Lar and B6JPolgLar/Lar animals had a 
spleen increase of almost twice the weight of the wild-type (Figure 3-2B). 
Our observations where anaemia in B6JPolgPro/Pro mice is milder than the anaemia exhibited 
in B6NPolgLar/Lar and B6JPolgLar/Lar animals, led us to suspect that the main factor for the 
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phenotypical differences is the allele expressed. This idea was supported by the 
cardiomyopathy data, where the less affected mouse line was the mutator B6JPolgPro/Pro.   
 
 
Figure 3-2. Anaemia and cardiomyopathy phenotype in the mtDNA mutator mouse lines. A) 
Heart weight ratio of 35 week-old mice (normalised to wild-type) (n=3-10). B) Spleen weight ratio of 
35 week-old mice ratio (normalised to wild-type) (n=5-11). C) Percentage of erythrocytes and 
haemoglobin on peripheral blood of mice at 35 week-old (n=4-8). Data are represented as mean ± SEM. 
Two-way ANOVA *p<0.05; **p<0.01; ***p<0.001. 
 
 
3.3. Male mutators with Lar allele are sterile while 
mutators with Pro allele remain fertile 
Studies in humans and mice suggest that male age-related-infertility, in which the main 
feature is a deficient semen quality, correlates with impaired mitochondrial function (Gao 
et al., 2016; Nakada et al., 2006; Spiropoulos, 2002; Vaught and Dowling, 2018). In 
addition, studies have shown a link between male infertility and mtDNA point mutations 
and deletions, ultimately correlating the severity of the mitochondrial diseases with 
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infertility severity (Ji et al., 2017; Martikainen et al., 2017). Moreover, it has been described 
that the Larsson variant mtDNA mutator mouse shows reduced male fertility (Trifunovic et 
al., 2004). Therefore, we decide to assess fertility by analysing several aspects related to 
this phenotype. 
First, in order to determine the number of pups generated in each mouse line, we mated 
homozygous POLG male mutants to wild-type females. Our results showed that, in line with 
previous results, B6NPolgLar/Lar were infertile (Ross et al., 2013; Trifunovic et al., 2004), 
but surprisingly the B6JPolgPro/Pro only exhibited a reduced fertility (reduction of 42.8%) in 
comparison with wild-type mice (Figure 3-3A).  
 
 
Figure 3-3. Male fertility analysis. A) Number of pups per litter (n=5-7). B) Relative testes weight 
(%) at 10 weeks (n=3). Data are represented as mean ± SEM. Two-way ANOVA *p<0.05; **p<0.01; 
***p<0.001.  C) Haematoxylin and eosin staining (H&E) of the seminiferous epithelium in testes, 
sections from 10 week-old mice. Marked in the wt picture are the germinal epithelium (#) and spermium 
(&). 
 
Next, we measured the testes weight. We found that B6NPolgLar/Lar and B6JPolgLar/Lar testes 
were substantially lighter than those of wild-type mice; while B6JPolgPro/Pro showed no 
significant difference in comparison with wild-type animals (Figure 3-3B).  
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In addition, we analysed the seminiferous tubule morphology of the testes in sexual mature 
mice (10 weeks) because tubules display all spermatogenesis stages with high degree of 
cellular heterogeneity (Ernst et al., 2019; De Rooji and Russell, 2000). The results showed 
no visible defects present in the B6JPolgPro/Pro, while B6NPolgLar/Lar and B6NPolgLar/Lar 
exhibited a much more deteriorated structure: reduced germinal epithelium, a near-lack of 
spermium, and complete lack of spermatids (Figure 3-3C). These histological results in 
addition to the testes weight data suggested that mutator lines with the Lar allele 
(B6NPolgLar/Lar and B6JPolgLar/Lar) have remarkably deteriorated testes, while B6JPolgPro/Pro 
maintains a normal testis morphology.  
Since studies have demonstrated that mitochondrial respiratory defects can give rise to 
sperm abnormalities (Folgerø et al., 1993; Nakada et al., 2006; Vaught and Dowling, 2018), 
we next decide to compare the sperm quality among the mtDNA mutator mouse lines. 
First, we analysed the normal sperm count. In this regard, B6JPolgPro/Pro maintained normal 
sperm counts while B6NPolgLar/Lar and B6JPolgLar/Lar showed a significant reduction 
compared to the wild-type. Interestingly B6NPolgLar/Lar displayed the highest drop with 
almost a 90% reduction (Figure 3-4A).  
Second, we evaluated total sperm motility, which plays a major role in achieving pregnancy. 
According to with the 2010 WHO (World Health Organization) report (Cao et al., 2011), 
sperm motility is graded as follows: a) sperm with progressive motility, that are able to swim 
fast and in a straight line, b) sperm with non-progressive motility, that tend to travel in a 
curved or crooked motion, c) sperm either move their tail or are immotile. Many sperm have 
limited motility or even are immotile, and are restricted to the same spot, therefore not able 
to fertilise an oocyte. Since sperm need to swim forward and fast to fertilise the egg, motility 
refers to the sum of progressive sperm and non-progressive sperm capable to fertilise the 
egg, being the progressive sperm the ones with more chances to achieve fertilisation.  
Using computer-aided sperm analysis (CASA), we quantify the percentage of total motile 
sperm, which is sperm that exhibit motility of any form. Our results indicated that the 3 
mutator lines had a decreased sperm motility (Figure 3-4B), with   B6JPolgPro/Pro being the 
least affected, with only a 50% decrease; whereas B6JPolgLar/Lar was the most affected, with 
almost no motile sperm. Then, when we quantify the percentage of progressive sperm, 
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which is sperm that exhibit rapid and linear movement. Our results indicated that all three 
mutator mouse lines were similar affected in this regard (Figure 3-4B).  
 
 
Figure 3-4. Sperm analysis. A) Sperm relative count at 10 weeks (n=3). B) Sperm motility (%) at 10 
weeks (n=3), C) Quantification of sperm morphology: normal sperm, sperm with head defects and 
sperm with tail defects (n=3). D) Images show examples of variable sperm morphology. Data are 
represented as mean ± SEM. Two-way ANOVA *p<0.05; **p<0.01; ***p<0.001. Relative levels were 
normalised to the wt average. 
 
Third, we evaluated sperm morphology by visually counting; (i) the number of normal 
sperm, (ii) sperm with head defects (heads lacking the typical hook structure or with 
irregular forms) and (iii) sperm with tail defects (folded or broken tails) (Figure 3-4C). 
Results showed that the three mutator mouse lines exhibited a significant reduction of 
normal sperm in comparison with the wild-type: B6JPolgPro/Pro (60% reduction), 
B6NPolgLar/Lar (73% reduction), and the most severe in B6JPolgLar/Lar (89% reduction). We 
also found a remarkable tail defect increase on the three mutator mouse lines. Interestingly, 
only mutators with the Lar allele (B6JPolgLar/Lar and B6NPolgLar/Lar) showed an increase in 
the proportion of sperm with head abnormalities, while B6JPolgPro/Pro levels remained 
similar to the wild-type.  
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The data clearly showed that despite B6JPolgPro/Pro exhibiting a slight reduction in sperm 
quality, mice with this genotype are fertile, with normal testes weight and normal 
morphological testes structures. In contrast, mutator mouse lines with the Lar allele 
(B6JPolgLar/Lar and B6NPolgLar/Lar), are infertile and exhibit abnormalities in testes 
morphology and sperm quality. Among them, the most severe phenotype is showed in the 
B6NPolgLar/Lar line, in which the testes weight, sperm count and sperm motility values are 
highly altered.  
Finally, based on the observation that the allele expressed is a determinant factor in the 
fertility phenotype, we decided to investigate the Mendelian transmission in mutators with 
the same nuclear genetic background (C57BL6/J). When we crossed wild-type animals with 
heterozygous mutants, no significant difference from the expected Mendelian transmission 
rate was found for the Lar and Pro alleles. However, results from intercrosses of 
heterozygous mutants, the Lar allele produced only 8.5% of PolgLar/Lar pups, less than 
expected for Mendelian proportions. In contrast, the Pro allele did not significantly differ 
from normal Mendelian transmission (Table 3-2). 
 
 
Table 3-2. Allele transmission and comparison to the expected Mendelian rate. In the table, we 
show the cross, the number of animals totals counted, the percentage of animals obtained of each 
genotype and the percentage of animals expected according to Mendelian inheritance. In the last 
column, the values of Chi-Test.  
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3.4. Lifespan comparison demonstrates allele 
hypothesis  
One of the most remarkable characteristics of the mtDNA mutator mouse is the short 
lifespan. To date, this feature has been assessed in different research publications (Dillon et 
al., 2012; Kujoth et al., 2005; Mito et al., 2013; Ross et al., 2013; Someya et al., 2017; 
Trifunovic et al., 2004).  
 
 
Figure 3-5. Lifespan and Phenotype. A) Lifespan obtained using breeding scheme lacking maternally 
transmitted mtDNA mutation. Log-rank (Mantel-Cox) test, ****p<0.0001, ***p<0.001. B) Maximum 
and medium survival data, obtained from the lifespan curve, end points were determinate when mice 
showed strong signs of sickness. C) Representative photos of the mtDNA mutator mice at 40 week old. 
 
In this regard, it has been shown that maternally transmitted mtDNA mutations can shorten 
the lifespan in the mtDNA mutator mouse or wild-type animals, even at low levels (Ross et 
al., 2013, 2014). Therefore, using a breeding scheme lacking maternally transmitted 
mtDNA mutations, we analysed the lifespan in our three mtDNA mutator mouse lines 
(Figure 3-5A and 3-5B). The data showed that B6NPolgLar/Lar exhibits the shortest lifespan, 
followed by B6JPolgLar/Lar, and with the longest lifespan B6JPolgPro/Pro. In addition, the 
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median lifespan showed the same pattern. We found that Pro mutator has an approximately 
38% increased lifespan compared to mutators with the Lar allele.  
We could visualise the difference in progeria on the mutator mouse lines at 40 weeks old, 
when the ageing phenotype is evident (Figure 3-5C). As shown in the pictures, mice with 
the Lar allele exhibit stronger progeria characteristics like alopecia, greasy fur, kyphosis 
(curvature of the spine); being the B6NPolgLar/Lar evidently, the more affected line. 
 
 
3.5. Transcriptome analysis reveals a differential 
immune response between mutators with 
different alleles 
Because all our data confirmed that the expressed allele is evidently the major factor that 
gives as a result phenotypical differences among the mutator mouse lines, we performed the 
next experiments using only animals with the same genetic background (C57BL/6J) but 
with the different Polg alleles, B6JPolgPro/Pro and B6JPolgLar/Lar. 
To explore whether other biological processes were regulated differentially between the Lar 
and Pro allele, we examined global patterns of gene expression by RNA-Seq, using total 
RNA from the hearts of mice at 35 weeks old. Taking into account only genes with adjusted 
p-value <0.05, we observed 1,169 differentially expressed genes in B6JPolgLar/Lar samples 
compared to wild-type samples. Strikingly, we only observed 312 dysregulated genes in 
B6JPolgPro/Pro samples. From these, B6JPolgPro/Pro and B6JPolgLar/Lar shared 235 
dysregulated genes (Figure 3-6A and 3-6B). Supplementary figures S3, S4 and S5 contain 
the data of the 40 genes most dysregulated in each mutator mice strain.  
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Figure 3-6. Heart-RNA-Seq Analysis. RNA-Seq data obtained from heart RNA of mice at 35 week 
old. Data using as a reference wild-type values and only genes with an adjusted p-value <0.05 (n=3). A) 
MA plot showing log2-fold expression ratio vs average log2-expression, identified in B6JPolgPro/Pro 
compared to B6JPolgLar/Lar. Genes expressed differentially are highlighted in red. B) Venn diagram of a 
number of differentially expressed genes between B6JPolgPro/Pro and B6JPolgLar/Lar. C) Genes identified 
with MitoXplorer, changing in B6JPolgPro/Pro and B6JPolgLar/Lar. D) Hierarchical cluster dendrogram of 
signalling pathways between B6JPolgPro/Pro and B6JPolgLar/Lar (filter: only signalling pathways, p-value 
cut-off at 1.5 and z-score cut-off at 1.5). E) MD plot showing log2-fold expression changes vs average 
log2-expression identified in B6JPolgPro/Pro compared to B6JPolgLar/Lar. Genes implicated in immune 
signalling pathways are highlighted in red. F) Hierarchical cluster dendrogram of activated or inhibited 
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pathways between B6JPolgPro/Pro and B6JPolgLar/Lar (filter: only immune-related signalling pathways, p-
value cut-off at 1.5 and z-score cut-off at 1.5).  
 
Next, we narrowed our focus on genes with established roles in mitochondria (Figure 3-
6C). Using the web-platform mitoXplorer v.1.0 (http://mitoxplorer.ibdm.univ-mrs.fr/) (Yim 
et al., 2019), we identified genes dysregulated in oxidative phosphorylation, translation, 
amino acid metabolism, mitochondrial carrier pathway, pyruvate metabolism, and 
glycolysis pathways. Overall, the data showed higher numbers of dysregulated 
mitochondrial genes in mice with the Lar allele compared with Pro allele mice (Figure 3-
6C) (Complete list of genes in Table 3-3). While we did not detect dysregulated genes 
related to oxidative phosphorylation in B6JPolgPro/Pro samples, we detected 17 genes down-
regulated in B6JPolgLar/Lar samples: 7 genes for complex I, 5 genes for complex V, 3 genes 
for complex IV and 2 genes for complex III.  
Finally, in order to identify signalling pathways changing between the B6JPolgPro/Pro and 
B6JPolgLar/Lar, we performed a functional enrichment analysis using the QIAGEN’s 
Ingenuity Pathway Analysis software (IPA, 
https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/). The IPA 
enrichment algorithm uses two scores to determine different aspects: 1) P-value score, based 
on Fischer’s exact test, where the P-value represents the significant overlap between the 
predicted and the regulated molecules. 2) Activation Z-score, which is a prediction for 
activation or inhibition of significant pathways (Krämer et al., 2014).  
When we analysed our data using the p-value score, we identified 37 biological pathways 
significantly dysregulated in B6JPolgPro/Pro and B6JPolgLar/Lar (Filter: only signalling 
pathways) (Figure 3-6D). Interestingly, a large number of differently expressed genes were 
related to immune response signalling pathways (Figure 3-6E). Therefore, we decided to 
analyse the activation and inactivation of the immune-related signalling pathways using 
Activation Z-score. Using as a filter for only immune-related signalling pathways, the data 
indicated that some immune pathways were activated in both mutant mice (Figure 3-6F). 
However, a differential response was found in pathways like interferon signalling, IL-9 
signalling and T-cell exhaustion signalling, where activation was found in B6JPolgLar/Lar 
mice but not in B6JPolgPro/Pro. A complete list of these genes is reported in Supplementary 
Figure S1.  
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Figure 3-7. White Blood Cell counts on peripheral blood of mice. Data (n=4-8) are represented as 
mean ± SEM. Relative levels were normalised to the wt average. Two-way ANOVA *p<0.05; **p<0.01; 
***p<0.001. 
 
The activation of immune-related pathways in the mutator mouse lines prompted us to 
investigate whether the immune system cells were being mobilised in peripheral blood. 
Therefore, we analysed the total count of white blood cells in the mouse lines.  The results 
revealed that B6JPolgLar/Lar samples showed a reduction of 60.3% in the number of 
basophils, while B6JPolgPro/Pro mice only showed a 30.5% reduction. In addition, 
B6JPolgLar/Lar mice showed a dramatic increase in the number of neutrophils (up to 224%), 
but the levels were not altered in mice with the B6JPolgPro/Pro allele. We also performed 
Toluidine staining in heart, skeletal muscle and colon (Supplementary Figure S7) to identify 
if mast cells (the type of cells implicated in the activation of the immune response by the 
release of histamine and heparin) were being mobilised to these tissues. However, we did 
not observe any difference in comparison with wild-type samples.  
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Table 3-3. Genes up- or down-regulated obtained from RNA-Seq of hearts at 35 week-old mice. 
L, denote genes dysregulated between B6JPolgLar/Lar and wild-type samples; P, denote genes dysregulated 
between B6JPolgPro/Pro and wild-type samples. L,P, denote genes dysregulated in both B6JPolgLar/Lar and 
B6JPolgPro/Pro in comparison to wild-type. Only genes with an adjusted p-value <0.05. 
 
 
3.6. SNPs on the POLG Pro allele and possible 
consequences  
Lar and Pro alleles were generated using two different gene-editing methodologies to 
generate the same POLG D257A protein mutation (i.e. plasmids, codon sequence, 
recombination systems); for this reason, they harbour differences at the nucleotide sequence 
level (See diagram 3-9). Briefly, in the POLG Lar allele (Trifunovic et al., 2004), the codon 
GAC (aspartic acid) at the position 257 (exon 3), was exchanged for codon GCC (alanine). 
In addition, as a result of the methodology used, the final allele harbours two loxP sites 
flanking the exon 3, and one Frt site upstream exon 3. Whereas in the POLG Pro allele 
(Kujoth et al., 2005), the position 257, the aspartic acid codon was exchanged for the codon 
GCT (alanine) and, as a result of the methodology used, the final allele contains a loxP site 
downstream of the exon 3 (Figure 3-9A). Therefore, to determine if these expected 
nucleotide sequence differences between the Lar and Pro allele were affecting the 
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phenotype, we first sought  to confirm that no other mutations were present in these  
POLGD257A alleles. 
Unexpectedly, the alignment using RNA-seq data revealed that the Pro allele contains 
several single nucleotide polymorphisms (SNPs) in comparison to the GRCm38.p6 
reference genome assembly from the substrain C57BL/6J (Genome reference of Mus 
musculus).  As a result of these SNPs, the final protein should contain 4 non-synonymous 
substitutions (S27A, S308P, S665N, S1023A) and 3 additional synonymous substitutions 
(G74G, I228I, T525T), in addition to at least 8 nucleotide changes on non-coding regions 
(Figure 3-8). Meanwhile, the Lar allele was found to be identical to the current reference 
genome assembly GRCm38.p6.  
From the SNPs that are in the coding sequences, of high relevance is the SNP that generate 
the substitution S308P, as is located within the exonuclease domain. The rest of the 
synonymous and non-synonymous substitutions are located outside of the exonuclease and 
the polymerase domain (according to Pfam arrangement Q05BB8, 
https://www.uniprot.org/uniprot/Q05BB8). In addition, SNPs, close to the 3’ UTR region 
and changes at the exon-intron boundary downstream exon 4 may have functional 
relevance, as splicing can be disrupted. 
 
 
Figure 3-8. Scheme showing the POLG Pro allele and polymorphisms localised by RNA-seq-based 
mapping. In red are denoted non-synonymous substitutions, in blue synonymous substitutions, in 
yellow are the SNPs on non-coding regions. The D257A mutation is indicated by a red *. 
 
During splicing, exons are removed from primary transcripts at conserved sequences called 
splicing sites. These splicing sites are critical consensus sequences located at the 5’ and 3’ 
ends of the introns (Reviewed in (Sibley et al., 2016). Therefore, one of the possible effects 
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of the nucleotide changes downstream of the exon 4 (AA>GG, A>G, and C>A) is  the 
creation of a pseudo-splice site, which could lead to an altered splicing process (Anna and 
Monika, 2018). To explore if a splicing problem was occurring between the exon 3 and exon 
4, we analysed the transcript levels of POLG in skeletal muscle and spleen of 35-week-old 
mice by RT-qPCR. Using a TaqMan probe spanning the junction exon 2 – exon 3 (figure 3-
9A, grey arrows) and a probe spanning the junction exon3-exon4 (figure 3-9, green arrows), 
we could compared the proportion of mature RNA before and after the exon-intron 
boundary at risk. We added as a control, samples from hemizygous B6JPolgMut/ko mice 
(harbouring a POLG knock-out allele and either the Lar or Pro allele); since they only 
contain one allele and have been shown to  contain half the steady-state levels of PolG 
mRNA (Hance et al., 2005).  
The RT-qPCR data in skeletal muscle (Figure 3-9B) and spleen (Figure 3-9C) showed no 
significant difference in transcript levels when comparing mRNA spanned from exon 2-3 
versus mRNA spanned from exon 3-4, meaning that with qPCR we could not detect any 
splicing alterations in the steady-state RNA pools of any of the mutator mice.  
To gain more detailed insight about the mRNA processing between Lar and Pro allele, we 
decided to generate a compound heterozygous mutator mouse: B6JPolgLar/Pro. We obtained 
this new mouse line by crossing heterozygous mutants B6JPolgLar/wt and B6JPolgPro/wt.  
In order to detect different RNA species, we generated two pairs of primers: (i) a pair of 
primers to amplify the exon3-exon4 junction (Figure 3-9A, pink arrows), which will amplify 
the mature mRNA, and (ii) a pair of primers to amplify from the exon 3 to an intronic region, 
to detect pre-mRNA (Figure 3-9A, orange arrows). Taking advantage of the codon 
differences at the third codon of the D257A alleles, and the newly discovered variations 
between Lar and Pro allele, we were able to reveal the RNA relative levels produced from 
each allele. 
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Figure 3-9. RNA processing analysis. A) Draw showing the Lar and the Pro allele from exon 2 to exon 
4. Indicated by a red (*) is the D257A mutation and the codon used to generate the mutant alanine. In 
addition,  dotted lines indicate the loxP and Frt sites and the location of the nucleotide changes close to 
the splicing sites.  At the bottom are the locations of the primers and probes used to amplify specific 
fragments of RNA are shown.  B) and C) are the POLG transcript levels determined by RT-qPCR on 
total RNA isolated from skeletal muscle and spleen, at 35 weeks old. Normalization to Tbp or B2m 
(n=2-5). Relative levels were normalised to the wt average. Data are represented as mean ± SEM. Two-
way ANOVA *p<0.05; **p<0.01; ***p<0.001. E) Pyrosequencing analysis of the ratio of Lar (Purple) 
and Pro (blue) alleles in cDNA from compound heterozygous mice B6JPolgLar/Pro at 10 weeks old (n=4).   
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Using cDNA from heart, colon, liver and skeletal muscle of B6JPolgLar/Pro mice at 10 weeks 
old, we performed allele-quantification Pyrosequencing. Theoretically, if both alleles were 
expressing equally, we could expect approximately 50% expression of each allele, either 
from the pre-mRNA or from the mRNA. We found that in all the analysed tissues, the 
proportion of mRNA expression of the POLG was ~40% Pro allele and ~60% Lar allele 
(Figure 3-9D). In contrast, when we analysed the pre-mRNA expression in heart, the 
proportions were inverted, with RNA derived from the Pro allele being more abundant 
(Figure 3-9E). These results show that there is more Pro pre-mRNA in the B6JPolgLar/Pro 
mice at the steady-state level, in comparison with Lar pre-mRNA, and the proportion of Pro 
mature mRNA is lower than the Lar counterpart, implying altered splicing between exon 3 
and 4.  
 
Figure 3-10. POLG transcript levels in different tissues. POLG transcript levels determined by RT-
qPCR on total RNA isolated from mice at different ages (10 or 35 week old) and in different tissues 
(skeletal muscle, spleen and heart). Hemizygous B6JPolgMut/KO mice were used as knockdown controls.  
Normalisation was to the Tbp mRNA (n=2-6). Relative levels normalised to wt average. Data are 
represented as mean ± SEM. Two-way ANOVA *p<0.05; **p<0.01; ***p<0.001. 
 
Our next question was to analyse POLG transcript levels across different tissues. To address 
this question, we compare RT-qPCR data of skeletal muscle, spleen and heart of mice at 35 
weeks old. Our data showed no statistical difference in steady-state mRNA levels in spleen 
and heart samples between mutators and with wild-type samples. However, in skeletal 
muscle data at 35 weeks old, we detect an increase in POLG transcript levels in 
B6JPolgPro/Pro and a decrease in B6JPolgLar/Lar (Figure 3-10).  To determine if this variation 
was also visible in younger animals, we decide to analyse the same tissue in 10 week-old 
mice. The results indicate that at a young age, the levels were not affected (Figure 3-10).  
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3.7. POLG protein levels are not affected by the 
allele expressed   
The results above prompted us to investigate the POLG protein levels in the mutator mouse 
lines. Therefore, we proceeded to assess by western blot the POLG expression. Because 
POLG is expressed at low levels in the cell, we used protein from mitochondria purified 
from the heart. In our analysis, we did not detect a difference in the POLG protein levels 
between genotypes (Figure 3-11A and 3-11B).  As before, we used hemizygous 
B6JPolgMut/ko animals as controls, to show that our assay was able to detect a 50% decrease 
in POLG levels.  Taking together transcript level and protein level results, the data suggests 
that no alteration in POLG protein steady state levels could be resolved between the 
genotypes by western blot/antibody detection. 
 
 
Figure 3-11. POLG protein levels. A) Western blot of POLG levels in mitochondrial extracts from the 
heart of mice at 35 week old (lines 1-7, 9-11, 13-16) and 10 week old (lines 8 and 12). B) Western blot 
quantification of POLG protein levels.  Normalization to TOM20 and VDAC. Relative levels were 
normalised to the wt average. Data are represented as mean ± SEM. One-way ANOVA *p<0.05; 
**p<0.01; ***p<0.001. 
 
 RESULTS 
64 
3.8. Mutation rates and COX-deficiency 
differences between Lar and Pro allele 
Once we had determined that Lar and the Pro alleles were genetically different, we decide 
to explore if the alleles were showing differences in mtDNA mutation load.  
Previous reports have demonstrated that female mice with Polgmut/wt transmit mtDNA 
mutations through their oocytes, which can reach relative levels above 1% in the offspring 
(Ross et al., 2013). Therefore, to avoid maternally transmitted mutations in the 
quantification of mutation load, we decide to generate hemizygous mtDNA mutator mouse 
lines with only one mutant allele and a knock-out POLG allele. By crossing B6JPolgPro/wt 
and B6JPolgLar/wt males with heterozygous knock-out B6JPolgwt/ko females, we generate two 
new lines of the mice. These new lines were containing the Lar and the Pro allele, but 
lacking germline transmitted mutations, here labelled these hemizygous as B6JPolgLar/ko and 
B6JPolgPro/ko, respectively  
Using high-quality enriched mtDNA samples as previously described by Isokallio et al., 
(2018), we extracted mtDNA from the liver of young mice (11-14 weeks old), then we 
sequenced with an Illumina HiSeq3000 in 1 x 150bp read mode.  Our results showed the 
same patterns of per-base coverage depth between the hemizygous mutant samples (Figure 
3-12A).  
We estimated the total mutation rate (transitions, transversions, and single-nucleotide 
indels) by dividing the number of mutations between the total of reads per sample. Our data 
(Figure 3-12B), indicate that both hemizygous mutants had an elevated frequency of 
mutations compared with the wild-type samples as previously reported (Ross et al., 2013). 
Interestingly, B6JPolgPro/ko samples exhibit a slightly lower mean mutation load of 7.5x10-4 
mutations/bp in contrast to the 9.9x10-4 mutation/bp in B6JPolgLar/ko samples.   
One characteristic of the mtDNA mutator mice is that approximately 30% of the mtDNA 
molecules are short linear truncated pieces of mtDNA containing the major arc between the 
replication origins OriH and OriL (Figure 3-14) (Ameur et al., 2011; Bailey et al., 2009; 
Trifunovic et al., 2004). We detected a decrease in the sequence coverage of the minor arc 
between the two origins of replications, which corresponds to the previously reported 
deleted region from the truncated linear double-stranded mtDNA molecules (Figure 3-14) 
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(Ameur et al., 2011; Bailey et al., 2009; Edgar and Trifunovic, 2009; Trifunovic et al., 
2004).   
 
 
Figure 3-12. mtDNA mutation rates in POLG mut/ko mice. A) Sequence coverage across the 
mtDNA of sequenced samples with Illumina. The mitochondrial genome position is located at the x-
axis and the sequence coverage divided by maximum coverage for each sample at the y-axis. Each line 
corresponds to the mean depth of 3 samples of mtDNA isolated from the liver of 10 week-old mice. 
The approximate locations of the origins of light-strand (OL) and heavy-strand (OH) are also shown. B) 
Mutation frequency was calculated by dividing the number of mutations (transitions, transversions and 
single-nucleotide indels) by the total of reads. One-way ANOVA *p<0.05. C) Linear deletions were 
calculated by dividing the number of mutations in the region CR-Cox1 by the Wancy t-RNA-cluster 
region. One-way ANOVA were ns= no significate. 
 
To investigate if the relative amount of linear deletions differs due to the POLG allele 
expressed, we quantify these deletions dividing the number reads with the major arc region 
(which is present in linear deletion and wild-type mtDNA molecules) by the minor arc 
region (which is absent in the linear deleted molecules) (See figure 3-14). As expected, our 
results showed that hemizygous mutants contain a high level of deletions, which were absent 
in the wild-type samples. However, we did not find a detectable difference between 
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B6JPolgLar/ko and B6JPolgLar/ko samples, showing both samples an increase in the major arc 
sequencing coverage of 1.5x (Figure 3-12C).  Taking together, our results showed a very 
mild increase in the mutation rate in mice with Lar allele, without alteration in relative levels 
of linear deletion molecules between hemizygous mutants. 
 
 
Figure 3-13. Mitochondrial COX deficiency. A) Representative pictures of NBTx staining in heart, 
colon and skeletal muscle at different ages. Blue colour indicates COX defective cells. B) Quantification 
by category (low, intermediate and high) of COX deficiency in heart tissues of 35 week-old mice using 
NBTx staining and computer quantification (n=4-6). C) Quantification of COX deficiency of colon 
tissues in 35 and 10 week-old mice, using COX/SDH staining and counting manually the number of 
crypts (n=5-7). In all graphs, data are represented as mean ± SEM. Two-way ANOVA *p<0.05; 
**p<0.01; ***p<0.001. 
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Next, we assessed mitochondrial function (Cytochrome c oxidase deficiency) in various 
postmitotic tissues of homozygous mutators. Cytochrome c oxidase (COX) is a partially 
mitochondrial encoded complex that can have an impaired function due to mutations 
(mitochondrial or nuclear) affecting directly COX subunits or mutations affecting the 
complex assembly (Rak et al., 2016). Moreover, a decreased or lack of COX function can 
also be the result of mitochondrial protein synthesis impairment (Horvath et al., 2009). 
However, a direct co-relation has been shown between mtDNA mutations and COX 
deficiency by the generation of respiratory chain complexes instability (Edgar et al., 2009). 
Additionally, this mutations can be clonally expanded, creating a mosaic pattern of 
respiratory chain deficiency in the tissues (reviewed by Alston et al., 2017).  
Therefore, we performed in heart, skeletal muscle and colon, histochemical analyses to 
reveal cytochrome c oxidase (COX) activity variability between mutators and to know if 
(indirectly) there is a correlation with mitochondrial mutation loads. We decide to use the 
NBTx technique (Simard et al., 2018) because it allows us to detect and quantify (in the 
heart) with high sensitivity any mitochondrial COX deficiency. This method is based on the 
assessment of blue colour in tissue samples, due to formazan crystals from reduced 
tetrazolium salts in cytrochrome c oxidase-deficient mitochondria. To perform the assay, 
two main components are added: 1) PMS (phenazine methosulphate), which is a strong 
electron carrier, 2) NBT (nitro blue tratrazolium), which can be reduced to form blue 
formazan crystals. In COX-competent mitochondria, no reduction occurs because electrons 
are passed to molecular oxygen via electron acceptors located in COX subunits; however, 
in COX-deficient mitochondria, electrons are passed to NBT, triggering the NBT reduction 
into the formation of blue formazan crystals. Visual inspection indicated that B6JPolgLar/Lar 
has more COX deficiency in all tested tissues (heart, skeletal muscle (quadriceps) and 
colon), while B6JPolgPro/Pro mice only showed a milder phenotype (Figure 3-13A). To 
confirm the visual data, we quantify with the software ImageJ, the images obtained from 
the heart (Figure 3-13B). The results show a dramatic increase in COX deficiency in 
B6JPolgLar/Lar compared to B6JPolgPro/Pro.  
In the colon, due to the tissue shape (lack of homogeneity and separation of the crypts), we 
choose to perform COX/SDH staining. Counting manually in the microscope the number of 
COX deficient crypts and the number of normal crypts, we obtained the percentage of 
mitochondrial dysfunction (Figure 3-13C). Our results clearly showed that there is a higher 
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number of mitochondrial COX dysfunction colonic crypts in mutators expressing the Lar 
allele.   
 
 
3.9. Differences in Replication between Lar and 
Pro allele 
 
 
Figure 3-14. Schematic representation of the mtDNA. In red, the probes used to analyse mtDNA 
copy number, in green the control region and the D-loop, in blue the fragment absent in the linear 
mtDNA deletions, also of relevance are marked the light strand (OriL) and heavy strand (OriH) 
replication origins and the minor and major arc. 
 
Finally, we decide to analyse if mtDNA replication could be affected by the Lar or Pro 
allele expressed. Therefore, we analysed mtDNA copy number by relative qPCR 
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quantification. This assay allows us to determine if a difference in mtDNA steady-state was 
occurring between the Lar and Pro mutator mice. Additionally, we used two different 
probes to confirm the previous result about no difference in the level of the mtDNA linear 
deletions.  
We choose a Taqman probe that expands the ND4 gene, which is located in the major arc 
between the replication origins OriH and OriL. We also used Taqman probes for 16s or 
ND2, because these are genes from the fragment not present in the linear deleted mtDNA 
molecules (Figure 3-14). To normalise our data, we used a nuclear-encoded 18s probe. 
Using DNA samples extracted from liver and colon at 10 weeks old and 35 weeks old 
respectively, the results (Figure 3-15A) showed that in the 3 lines assessed (wild-type, 
B6JPolgLar/Lar and B6JPolgPro/Pro) mtDNA copy number was not altered, either using the 16s 
or ND2 probe. Suggesting no alterations in the copy number of full-length mtDNA.  
In agreement with our previous results (Figure 3-12A), the data using the ND4 probe 
confirmed the presence of the linear deleted mtDNA molecules in the mutator mice, and 
this is more evident in liver samples. However, we did not detect a difference between 
B6JPolgLar/Lar and B6JPolgPro/Pro in either liver or colon. 
 
 
Figure 3-15. Mitochondrial DNA copy number. A) mtDNA copy number determined by qPCR on 
total liver DNA isolated from mice at 10 week old using 16s and ND4 probes. B) mtDNA copy number 
determined by qPCR on total colon DNA isolated from mice at 35 week old using ND2 and ND4 
probes. Normalization to 18S (n=4-6).   
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Since several studies have established that TFAM (mitochondrial transcription factor A) 
protein levels strongly correlates with mtDNA copy number (Larsson et. al., 1998, Ekstrand 
2004, Kukat 2015), we carried out TFAM quantification by Western blot. Using 
mitochondria protein isolated from the heart and as an additional control samples from 
B6JPolgMut/ko mice, the data indicated no variation in TFAM protein levels between wild-
type, B6JPolgLar/Lar and B6JPolgPro/Pro samples (Figure 3-16A and 3-16B).  
Taking together mtDNA copy number by qPCR and protein levels of TFAM by Western 
blot, results suggest no substantial variation in steady state mtDNA copy number in these 
post-mitotic tissues. 
 
 
Figure 3-16. TFAM protein levels.  A) Western blot on samples from isolated heart mitochondria of 
10 week-old mice. Antibody for TFAM. Normalization to VDAC. Relative levels were calculated to the 
average normalised of wild-type. Data are represented as mean ± SEM. Two-way ANOVA ***p<0.001. 
 
We next proceeded to study ex vivo function of the POLG coded by each allele. Therefore, 
we conducted mitochondrial DNA replication in organello assay, as previously described 
in (Enríquez et al., (1994)). Briefly, we incubate for 2 hours freshly isolated mitochondria 
with dNTPs were the dATPs is radioactively labelled with Phosphorus-32 (P32). As a result, 
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de novo synthesised mtDNA is radioactively labelled. Additionally, to follow the stability 
of the newly synthesised mtDNA, we performed a subsequent 1-hour chase. Samples were 
analysed in the native and denatured forms. At the end of the protocol, and once the signal 
of P32 was no longer detectable, the DNA levels were analysed by performing a Southern 
blot to detect total mtDNA (PAM1 probe). 
First, we analysed de novo mtDNA synthesis in mouse samples at 10 weeks old. We 
detected an increase of newly synthesised mtDNA in B6JPolgLar/Lar samples, and no 
difference was found between wild-type and B6JPolgPro/Pro samples. We also detected that 
de novo mtDNA remains stable in all samples after 1 hour, as an abundant band is present 
in the native chase gel. The main results are shown in Figure 3-17A, and quantifications by 
ImageQuant software are shown in Figure 3-17A, 3-17B, 3-17C. It is important to mention 
that this result is different in samples of mice at 38 weeks old, where we saw a decrease in 
de novo mtDNA (Supplementary Figure S8). 
However, intriguing results were observed for the 7S DNA fragment. Is has being described 
that most of the mtDNA replications events are abortive due to premature termination, 
generating 7S DNA fragments. The called 7S DNA is a linear DNA strand of approximately 
650 nucleotides, which forms a characteristic triple-stranded DNA structure (the D-loop) 
(Reviewed by (Nicholls and Minczuk, 2014)). In our results, the de novo canonical 7S DNA 
fragment is absent in the mutator samples, with a more prominent depletion in the 
B6JPolgLar/Lar (Figure 3-17A and 3-17C).  
Additionally, we observed that samples from the mutators generate a strong smear, which 
migrated slower than the 7S DNA band. When we quantify this area, we detected more 
isotope incorporation in B6JPolgLar/Lar samples (Figure 3-17A, 3-17 D). Moreover, with the 
chase experiments, we found that these fragments are stable after one hour (observed in the 
denatured chase). Because of the size, we hypothesise that this smear is longer 7S DNA 
fragments, produced by the control region multimers (CRM) (Williams et al., 2010). The 
CRMs are thought to be partial duplications of the D-loop region, generated by the gain of 
strand displacement activity in the exo- deficient POLG mutators (Macao et al., 2015). To 
determine if the smears were longer 7S DNA fragments, and to determine the levels of these 
fragments at the steady-state level, we decide to performed Southern blot with a 7S probe. 
The results (Figure 3-18A and 3-18B) showed that the samples obtained from the mutator 
mice lack a defined band 7S. We also detect a smeared area with the 7S probe, implying 
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that these fragments are indeed longer 7S fragments due to the generation of control region 
multimers. Moreover, the quantification of the smeared area indicates that mutator samples 
with the Lar allele contain slightly more smeared 7S fragments, implying a more extensive 
generation of these aberrant products by the Lar POLG.  
 
Figure 3-17. Mitochondrial replication analysis. A) In organello assay in mitochondria isolated from 
heart of 10 week-old mice. We show the samples from the denatured pulse and native pulse experiments, 
with the corresponding mtDNA steady-state levels using the probe PAM1, and protein input by 
Western blot with VDAC as a control. Denatured chase and native chase are also shown. Pulse was 
performed for 2 hrs and chase for 1 hour. B), C), D), Quantification of de novo mtDNA (B), de novo 7s 
(C), and de novo 7s smeared (D). Signals were normalised to the mtDNA steady state levels. In all graphs, 
data are represented as mean ± SEM. Two-way ANOVA *p<0.05; **p<0.01; ***p<0.001. 
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Taking together in organello assays and southern blot analysis, we conclude that there is 
variability in replication between the POLG generated by the Lar allele and the POLG 
generated by the Pro allele. Both alleles exhibit a lack of the canonical 7S DNA, and 
accumulation of multimers molecules derived from the partially duplicated control region.  
 
Figure 3-18. Southern blot analysis of SacI-digested mtDNA with 7S probe, and 18S probe. 
Quantification of steady-state levels of 7S and 7S smeared products. Signals were normalised to 18S. In 
all graphs data are represented as mean ± SEM. Two-way ANOVA *p<0.05; **p<0.01; ***p<0.001. 
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4. DISCUSSION 
The mtDNA mutator mouse model contains a D257A mutation in the exonuclease domain 
of the POLG, which generates a mouse with an exonuclease deficient mitochondrial POLG 
protein. To date, three mutators with the same D257A POLG mutation have been described. 
These three mice display premature ageing; however, they show remarkable differences in 
their lifespan and the onset of the ageing phenotype. The first aim of this thesis was to 
determine, whether these variations were due to variations in the genetic background (a 
result of genetic differences between the substrains used), or the mutant POLG alleles 
expressed (which contain variations because of the different approaches to construct the 
mutants). The second aim of this thesis was to investigate the molecular mechanisms 
involved in the phenotypical variation. 
Mutator mice reports from 2004 and 2005 (Trifunovic et al., 2004 and Kujoth et al., 2005) 
clearly showed differences in median lifespan and onset time of the ageing phenotype. 
However, it was not until 2013 that experiments by Ross and colleagues demonstrated that 
maternally transmitted mutations can directly affect the lifespan (Ross et al., 2013). 
Therefore, it was highly relevant for us to compare the phenotype of the mutators under the 
same breeding scheme, lacking excess maternally transmitted mtDNA mutations that can 
occur by successive breeding of heterozygous PolGD257A/WT females. Our results confirmed 
the previously reported lifespan difference between the B6NPolgLar/Lar (mouse published by 
Trifunovic et al., [2004]) and B6JPolgPro/Pro (mouse published by Kujoth et al., [2005]) 
(Figure 3-5B).  
To decipher the main reason for this phenotype variability among the mutators we analysed 
whether the genetic background lead to this variability. Previously, several reports have 
shown that the substrain C57BL/6J (B6J), used by Kujoth et al., (2005); and the substrain 
C57BL/6NCrl (B6N), used by Trifunovic et al., (2004) are different. These two substrains 
have been separated for almost 70 years, which has generated the accumulation of 
significant genetic variations (Kiselycznyk and Holmes, 2011). An earlier genomic analysis 
revealed that these two substrains contain at least 34 single nucleotide polymorphisms, 2 
indels and 15 structural variants within the coding regions of the mouse genome  (Simon et 
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al., 2013). As a result, the substrains exhibit several phenotypical differences in metabolism, 
behaviour, and susceptibility to diseases (Eisfeld et al., 2019; Matsuo et al., 2010; Simon et 
al., 2013; Stiedl et al., 1999). For instance, B6N carries a mutation in the Crumbs homolog 
1 gene (Crb1) (Mattapallil et al., 2012) and B6J carries a mutation in the NAD(P) 
transhydrogenase gene (NNT) (Toye et al., 2005). Crb1 codes for a protein highly expressed 
in the eye and central nervous system of mice (Den Hollander et al., 2002). Loss of Crb1 
has shown to lead to retinal degeneration, and in humans is linked to a progressive 
degenerative disease that causes visual loss (Lotery et al., 2001). In addition, evidence 
shows that the severity of the symptoms is dependent on additional genetic factors like 
variations in the genetic background (Luhmann et al., 2015). NNT is a mitochondrial protein 
that catalyses the reduction of NADP+ by oxidising NADH and coupling proton 
translocation across the inner membrane to the matrix. Mice with this mutation display a 
differential response to insulin secretion and glucose tolerance (Freeman et al., 2006; Toye 
et al., 2005). Therefore, these mutations could be generating additional consequences at the 
phenotypical level as well as at the behavioural level.  
Our results demonstrate that mutators with the same Lar allele on different genetic 
backgrounds (B6NPolgLar/Lar and B6JPolgLar/Lar) do not show significant differences. 
Therefore, I conclude that the genetic background is not the main factor for phenotype onset 
among the mutators. However, in this thesis, I demonstrate by comparing mouse 
phenotypes, that the main factor implicated in the time variation when the symptoms appear 
and lifespan differences, is due to allele variation in the Polg gene. Our results show that by 
comparing B6JPolgLar/Lar and B6JPolgPro/Pro, which contain the same B6J genetic 
background, all the analysed phenotypes show a significant difference. 
For instance, analysing cardiomyopathy, which is one of the phenotypes that changes less 
between mutators, the data not show a significant difference between B6JPolgLar/Lar and 
B6NPolgLar/Lar. However, mice with the Pro allele (B6JPolgPro/Pro) show only a small 
increase in heart size. Data describing the anaemia phenotype shows similar results, with no 
significant difference between B6JPolgLar/Lar and B6NPolgLar/Lar mice that share the Lar 
allele and both showing a severe anaemia (50% erythrocyte reduction). On the other hand, 
in age-matched mice with the Pro allele, the number of erythrocytes shows only a mild 
reduction (22% reduction) and even more remarkable the spleen size is indistinguishable 
from wild-type samples, while substantially enlarged in the two lines bearing the Lar allele.  
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In other phenotypes, the allele differences are even more evident. For example, with male 
fertility, the testis structure and testis relative weight from mice with the Pro allele is 
indistinguishable from wild-type mice, whereas the mutator mice B6JPolgLar/Lar and 
B6NPolgLar/Lar show no difference between them and display substantial pathologies in 
comparison with wild-type samples.  However, sperm analysis reveal variations between all 
of our mutator mouse strains. The results show that the B6JPolgPro/Pro mouse has a better 
sperm quality than B6JPolgLar/Lar and B6NPolgLar/Lar mice, but large variations between 
B6JPolgLar/Lar and B6NPolgLar/Lar were detected in sperm quantity and quality (motility and 
morphology). While the nuclear genetic background may influence to some degree the 
ageing phenotype, for instance by variations in anaemia and sperm quality, the analyses 
presented here was unable to uncover any substantive difference.  
In the end, lifespan results agreed with the allele hypothesis. Even though the data showed 
a small, non-significant increase in median survival time between mice with the Lar allele 
(B6JPolgLar/Lar and B6NPolgLar/Lar), a ~1.4-times lifespan increase was found in mice with 
the Pro allele (B6JPolgPro/Pro). Maximum survival data also showed a 22 week increase in 
the lifespan of mice with the Pro allele, an increase of almost 40% in the maximum survival 
time. This result confirmed our hypothesis, that the main cause for the lifespan and onset of 
phenotype differences between the mutator mice is which of the transgenic alleles was 
expressed.  
This conclusion leads us to analyse in detail other phenotypical differences, specifically 
between the Lar and Pro allele. For instance, a highly remarkable distinction in immune 
response was identified in heart samples by RNA-Seq. Although data showed an increase 
in immune response in B6JPolgLar/Lar and B6JPolgPro/Pro samples, they show a remarkable 
difference in the degree of activation. For instance, data analysis could predict activation in 
B6JPolgLar/Lar in pathways like PI3K, IL-8, Oncostatin M (IL-6), IL-9 signalling, but not in 
B6JPolgPro/Pro. These signalling pathways have been shown to play important roles in 
differentiation, proliferation, activation of immune cells, and inflammatory pathways in 
general (Bickel, 1993; Goswami and Kaplan, 2011; Koyasu, 2003; Richards, 2013).  In 
addition to the computer-predicted data, our experimental results also support the hypothesis 
that a remarkable immune response activation is occurring in mutators with the Lar allele. 
White blood cell count data show an increase in the number of neutrophils (neutrophilia) in 
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addition to a decrease in the number of basophils (basopenia) only in B6JPolgLar/Lar 
mutators.  
Neutrophils are a type of leukocyte highly abundant in the blood. Among the main functions 
of them are phagocytosis of pathogenic microorganisms, degranulation (secretion of 
antimicrobial proteins, enzymes, and pro-inflammatory substances), the release of the 
nuclear material to form microbial traps (NETs), and interaction with other immune cells 
(Mortaz et al., 2018). Neutrophillia has been associated with immune responses to bacterial 
or fungal infections, inflammation, cancer, etc. It has been described that the increase in the 
number of circulating neutrophils is due to their release from the bone morrow and other 
marginated pools by inflammatory mediators like chemokines (Christoffersson and 
Phillipson, 2018). Our results show an increase of more than double in the number of 
neutrophils in mice with the Lar allele, supporting the idea of an increased immune response 
in B6JPolgLar/Lar.  
Basophils represent less than 1% of the blood leukocytes; however, they play an important 
role in the development and progression of Th2‐type immune responses and in chronic 
allergic inflammation. For instance, during basophil degranulation (activation) cytokines 
and chemokines are released (Sokol and Medzhitov, 2010).  Basopenia has not often used 
in diagnosis, because under normal conditions basophil counts are very low in the blood. 
Causes of basopenia include acute stress, for example during infection and haemorrhage, 
anaphylaxis, acute urticaria and other acute allergic reactions (Bain, 2015). On the contrary, 
an increase of basophils has been associated with other immune responses, e.g. chronic 
inflammatory diseases like rheumatoid arthritis, ulcerative colitis, some leukaemias, 
helminthiasis, influenza, smallpox, and tuberculosis (Nathan and Orkin, 2009). Our results 
show that B6JPolgLar/Lar mice exhibit low basophil counts in comparison with wild-type.  
Therefore, here I discuss three ideas to explain basopenia detected in B6JPolgLar/Lar. First, 
previous literature has described a dysfunctional repopulation of haematopoietic stem cells 
in the mutator mice (Ahlqvist et al., 2012; Chen et al., 2009; Norddahl et al., 2011; 
Wahlestedt et al., 2014). Since we did not detect a decrease in other types of blood cells 
(except erythrocytes), I hypothesise that maybe basophils are a sensitive population to 
haematopoietic stem cell dysfunction. A second theory is that maybe basophils are releasing 
their granules in response to inflammation, becoming empty and are therefore not being 
detected in the blood test. Lastly, it could be possible that basophils are migrating to specific 
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tissues, and therefore are not visible in the circulatory blood. It has been reported that there 
is a substantial reduction in the number of basophils in the blood of individuals experiencing 
allergic reactions (Korosec et al., 2017). However, when we did Toluidine staining (which 
stain basophils and mast cells) on colon, heart and skeletal muscle, we did not find any 
difference between wild-type and mutant tissues. However, I cannot discard the possibility 
that maybe the accumulation of basophils or mast cells is occurring in other tissues. 
Overall, our RNA-Seq data suggest an increased immune response in the mutator mice. In 
both mice B6JPolgLar/Lar and B6JPolgPro/Pro, RNA-Seq data predicts the activation of 
pathways like neuro-inflammation signalling, Th1 signalling, IL-7 signalling, leukocyte 
extravasation signalling, and acute phase response signalling. However, I was unable to 
elucidate the main factor triggering this response. Here I discuss some ideas. One hypothesis 
could be that the inflammation is triggered by the ageing process per se. Inflammaging is a 
term used to refer to a chronic low-grade inflammation that occurs in humans due to ageing. 
During ageing, tissues start to deteriorate. It has been suggested that the accumulation of 
damaged macromolecules and cells (self-debris) could trigger inflammation (Xia et al., 
2016). The second hypothesis is that, as I mentioned before, mtDNA is capable to activate 
neutrophils, which can indeed activate the immune response (Zhang et al., 2010). In 
addition, it has been proposed that IL-26, a cytokine derived from Th17 cells, could bind to 
cytosolic mtDNA triggering an antimicrobial immune response (Meller et al., 2015). 
Recently, it has been shown that during infection or mtDNA depletion, fragmented mtDNA 
can be released from the into the cytosol, triggering an antiviral immune response (STING-
IRF3-dependent signalling by the expression of interferon-stimulated genes) (West et al., 
2015). Also, studies have shown that mtDNA can be released from neutrophils into 
circulation by the activation of formyl peptide receptor-1 and Toll-like receptor 9 (TLR9) 
(Zhang et al., 2010). However, our RNA-seq data do not show any dysregulation on the 
genes reported by West et al. (usp18, Ifi44, Ifit1, Ifit3, Oasl2, Rtp4, etc.). Because I do not 
know what triggered the putative immune response in the mutators, I cannot discard the idea 
that inflammation is directly implicated in the lifespan and onset of ageing phenotype 
difference between the mutator mice.  
In this regard, there is a considerable amount of literature suggesting that mtDNA can be 
released from the mitochondria. For instance, neutrophils (Yousefi et al., 2009) and 
basophils (Morshed et al., 2014; Yousefi et al., 2015) can release mtDNA from during the 
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generation of NETs (Neutrophil extracellular traps) and BETs (basophil extracellular traps). 
In addition, it has been found that aberrant mtDNA packaging (by TFAM deficiency) can 
release mtDNA to the cytosol. This release can activate DNAsensors, like the cGAS-STING 
pathway, which activates interferon signalling and in the end activating antiviral signalling 
(West et al., 2015).  
It is important to mention that our RNA-seq data show disagreement with recent data 
published by Hämäläinen et al. (Hämäläinen et al., 2019). In their analysis, they found 
dysregulated pathways like TGF-β signalling, chemokine signalling, Wnt signalling, 
activation of the lysosome pathway, p53 signalling and RNA transport. Our data 
(Supplementary S2) using the same KEEG (Kyoto Encyclopedia of Genes and Genomes) 
database showed that the pathways linked to both mutator mice (that is B6JPolgLar/Lar and 
B6JPolgPro/Pro) were cancer pathways, PI3K-Akt signalling pathway, focal adhesion, Rap1 
signalling pathway and AMPK signalling pathway. Probably, this difference between 
Hämäläinen et al. and our data is related to the fact that they used iPSCs and not a tissue 
from an adult mouse where complex signalling occurs between the immune system and the 
tissues. Nevertheless, I found something interesting related to nuclear DNA damage. One 
of the genes with stronger downregulation in both mutator mice (B6JPolgLar/Lar and 
B6JPolgPro/Pro) is ERCC2 (Supplementary S3 and S4). This gene codes for a protein 
involved in the transcription-coupled nucleotide excision repair (NER), as part of the DNA 
repair factor IIH (TFIIH). In NER, TFIIH opens the DNA around the lesion allowing the 
repair (Rimel and Taatjes, 2018). However, no other proteins part of the TFIIH were 
dysregulated in our data. It would be interesting to determine if a downregulation of ERCC2 
is also occurring in tissues other than the heart, and if it is detectable at the protein level. 
Moreover, if the downregulation of ERCC2 has an effect on TFIIH activity.   
Another phenotypical variation caused by the allele expressed was detected when we 
analysed mitochondrial COX deficiency. Previous findings in the literature have shown that 
the mutator mice display an impaired assembly and stability of the respiratory chain 
complexes. In general, impaired stability has been demonstrated in complexes I and IV, and 
reported in complexes III and V (Ahlqvist et al., 2012; Edgar et al., 2009; Hiona et al., 2010; 
Woodall et al., 2019). Our RNA-Seq data are in agreement with these previous results; on 
our case, we detect downregulation of genes for complex I, IV and V. Interestingly, such 
dysregulation was only found in mutators with the Lar allele in this study. These data 
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correlate with our staining results, where we identified in heart, colon and skeletal muscle a 
higher COX deficiency in mice samples with the Lar allele. In this regard, point mutations 
have been demonstrated to cause respiratory chain deficiency in the mutator mouse (Edgar 
et al., 2009). As suspected, a slightly higher rate of mutation is detected in mouse samples 
with the Lar allele. All these results confirm a strong variability between the Lar and the 
Pro allele.   
Contrary to our expectations, using RNAseq data to investigate the genomic sequence of 
the Lar and the Pro alleles, the results show that the Pro allele contains unexpected 
polymorphisms. Because of these, the POLG protein variant from the Pro allele exhibits 
four amino acid substitutions, compared to the Polg reference from the B6J substrain. 
However, these polymorphisms are found in other divergent substrains like 129S, C3H or 
CBA.It is hard to predict what affects these amino acid variants would have on POLG 
activity. However, I suspect that the polymorphisms with a major impact in the variability 
of the phenotype may be the S308P (in the exonuclease domain), S665N (linker region) and 
S1023A (polymerase domain), since they are located at important functional domains of 
POLG. To date, almost 200 mutations have been described in the POLG associated with 
different diseases; however, very little is known about the effect of them. Moreover, when 
these mutations were tested in vitro or in yeast model systems, the results were not always 
as expected (Stumpf et al., 2013).  For instance,  the G517V substitution present in several 
syndromes like Leigh, neuropathy, myopathy and Kearns Sayre (Wong et al., 2008), does 
not show any decrease of catalytic functions in studies in vitro (Kasiviswanathan and 
Copeland, 2011).  
Our phenotypical characterisation of the mutator mice showed that the mice with the Pro 
allele exhibit a milder ageing phenotype.  Therefore, one possibility is that one or more of 
the amino acid variations of the Polg Pro variant could somehow diminish the effect of the 
D257A mutation. Although this seems to be a radical idea, a report by Chan et al. shows it 
is possible. In ataxia patients, the mutation W748S (in the exonuclease domain) often 
correlates with the E1143G substitution (in the polymerase domain) (Hakonen et al., 2005; 
Winterthun et al., 2005). Unexpectedly, evidence in vitro shows that the E1143G  
substitution reduces partially the effect of the W348S mutation (Chan et al., 2006). In the 
same way, the polymorphism S1023A, localised in the polymerase domain, could be 
reducing the impact of the deficient exonuclease activity in the Pro mutator mouse. Another 
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potentially impactful non-synonymous polymorphism is S665N, which is localised in the 
liker region. It has been described that the linker region interacts with one of the accessory 
subunits POLB (Lee et al., 2009) and that the binding of the POLB could suppress the 
exonuclease activity (Graziewicz et al., 2006). Therefore, I speculate that the S665N might 
also be modifying the effect of the deficient exonuclease activity in the B6JPolgPro/Pro 
mutator mouse. 
We also found important SNPs in non-coding sequences of PolG. First, there are sequence 
variations close to the exon 3, which could generate splicing variations; however, splicing 
changes are difficult to predict, particularly if new splicing sites are created (Adamson et 
al., 2018). Second, there are SNPs close to the 3’ UTRs (Figure 3-8) which are known to 
regulate mRNA stability, translation, and mRNA localisation (Mayr, 2017). We analyzed if 
sequence modifications of the 3’-UTRs could have an effect on the total mRNA’s 
expression, but our POLG expression data by qPCR do not show any changes between 
B6JPolgPro/Pro and WT mice in any tissue. However, using Pyro sequencing we did find 
mRNA POLG splicing abnormalities between the exon 3 and exon 4 using compound 
heterozygous mutator mice (Figure 3-9D and 3-9E). In our results, we detect that tissues 
were expressing more mature mRNA from the Lar allele, but more pre-mRNA from the Pro 
allele. I suspect that nucleotide changes downstream of the exon 4 (AA>GG, A>G, and 
C>A) could lead to splicing malfunction.  
At the protein level, there is not a significant difference in POLG expression between 
B6JPolgLar/Lar and B6JPolgPro/Pro. I am are aware that if a small variation in the POLG 
expression exists, it is plausible that with the Western Blotting technique used in our study, 
we would not be able to detect it. Additionally, it is important to mention that the detection 
of the POLG expression in the cell is difficult, since the POLG concentration is very low in 
the cells.  
Finally, our data demonstrate that the POLG expressed by the Pro allele shows replicative 
differences in comparison with the POLG expressed by the Lar allele. For instance, 
analysing mtDNA replication by in organello assay in heart samples of 10-week-old mice, 
we found an increase in de novo mtDNA replication in mutators with the Lar allele, while 
no significant increase (in comparison with wild-type) was observed in mutators expressing 
the Pro POLG. According to our Pyro-seq data, we found a differential splicing between 
alleles in compound heterozygous mice. Therefore, I suggest that if the Lar allele is being 
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more expressed than the Pro allele this could lead to major differences in the synthesis of 
mtDNA.  
Our data also show a difference in the de novo 7s DNA products, and 7s-like products 
derived from mtDNA bearing control region multimers. These results clearly show that 
there is variation in the Polg activity expressed by the respective alleles. Our results show 
that although both mutant alleles fail to generate the canonical sized 7s DNA fragments, 
mutants with the Lar allele show a lower amount of the canonical 7s fragments than mutants 
with the Pro allele (Figure 3-17C). Moreover, we visualised that mice with the Lar allele 
showed more of a smear of larger-sized DNA fragments that also binds the 7s probe (Figure 
3-17-D). I hypothesise that these fragments are products from the control region multimers 
previously described by Williams et al., (2010). It has been reported that mutator mice 
display control region multimers, probably created by defective mtDNA replication. It is 
suggested that when the polymerase, with a defective exonuclease activity, fails to halt at 
5’ ends and continues the mtDNA polymerisation, it creates a 5’-flap inefficient for ligation. 
Then, unligated ends are more likely to mis-pair within the control region, leading to small 
duplications (Macao et al., 2015). These duplicated control regions could produce mis-sized 
7s-like DNA products that we detect as smear in the in organelle assay. The difference in 
the multimer control region products, I suspect, is due to one or more of the substitutions 
generated by the SNPs that are modifying the activity of the Polg and as a result, the 
generation of these products. However, we cannot discard the possibility that these in 
organello variations are due to different amounts of Polg expression, because of the 
described splicing variations.  
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5. CONCLUSIONS AND FUTURE 
PERSPECTIVES 
Engineering mouse models to study mtDNA mutations is problematic. First, mitochondria 
are double membrane organelles, which makes difficult the access of chemicals and 
transfection methods. Second, the apparent lack or minimal recombination of mtDNA 
prevents the successful integration of foreign DNA. Third, the multi-copy and 
heteroplasmic characteristics make it difficult to analyse single mutations. Fourth, physical 
or chemical mutagenic agents not targeted specifically at the mitochondria will not only 
produce mtDNA mutations but also nuclear DNA mutations (Jang and Lim, 2018; Tuppen 
et al., 2010). Therefore, the mtDNA mutator mice is a very important animal model. It has 
allowed the generation of mutations in the mtDNA of mice that would not have been 
possible any other way (Kauppila et al., 2016). However, the main force driving the 
premature ageing phenotype in these mice, and the relevance as a model of normal human 
ageing are still under intense debate (Dogan and Trifunovic, 2011; Hämäläinen et al., 2019; 
Kraytsberg et al., 2009; Vermulst et al., 2008). To date, the mitochondria mutator mouse 
has already helped to reveal the putative consequences of a deficient proof-reading 
exonuclease POLG in humans (Dogan and Trifunovic, 2011) and clarify the principles of 
mtDNA mutated maternal transmission (Stewart et al., 2008).  
This study has demonstrated that although the genetic background influence to some degree 
the ageing phenotype, the main cause of the phenotypical differences exhibited by the 
different mutator mice strains is due to the Polg allele expressed. Our work reveals SNPs in 
the Pro allele that were derived from a divergent mouse line. In addition, I characterised 
some molecular mechanism differences exhibited by the different polymerases exhibited by 
each allele, including differences in the mutation rate, replication, and mitochondrial 
dysfunction.  
I am confident that our results have improved the knowledge of the mutator mice model and 
we consider it will be helpful to other researchers for future work with the mouse model.  I 
recommend taking into consideration our work during research projects using the mutator 
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mouse model, to avoid misinterpretation of data due to the existence of these two 
fundamentally different mtDNA mutator mouse strains. I also think our research improves 
the knowledge about the effect of POLG mutations and we hope it can be useful during 
mutation prediction in human diseases. 
I think future work needs to concentrate on characterising and confirming an immune 
response in the mutator mouse model and establishing the cause. I also think it is important 
to determine the cause of the increased immune response in the Lar mutator. Moreover, 
further investigations need to establish how this relates to humans, and if the mutator mouse 
can be used as an inflammatory mouse model. In this regard, I consider that a start would 
be to determine if mtDNA is been released to cytosol or circulation, and the actions of 
neutrophils and basophils in the mutator immune response.  
Future studies should also examine what are the implications of each of the substitutions 
found in the Pro allele, as we cannot discard the idea that some of these polymorphisms are 
rescuing the ageing phenotype. Therefore, this would be interesting for pathologies 
associated with the POLG.  
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6. SUPPLEMENTARY FIGURES 
 
S 1. RNA-Seq data of dysregulated genes associated to immune response signalling. Data from 
B6JPolgLar/Lar and B6JPolgPro/Pro. RNA samples were obtained from RNA-Seq of hearts at 35 week-old 
mice. Only genes with an adjusted p-value <0.05, taking as a reference wild-type samples. Also shows if 
there is significant variation in expression between B6JPolgLar/Lar and B6JPolgPro/Pro (p-value <0.05) and 
the respective fold-change between B6JPolgLar/Lar and B6JPolgPro/Pro.  
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 B6JPolgLar/Lar B6JPolgPro/Pro 
KEGG 
ID and 
Name 
Hits Genes Hits Genes 
mmu05200 
 
Pathways 
in cancer 
39 Fzd4, Cdk6, Ctnna3, Ccnd1, 
Cxcl12, Jak1, 
AC124712.1,Hif1a,Snapc1, Hif1a, 
AC124712.1,Hif1a, Snapc1, 
AC124712.1, Fgf12, Ret, 
Stat1,Stat4, Stat1, Stat4, 
Gm28177, Sos1, Igf1r, Adcy4, 
Pik3cg, Apc, Gnb3, Cdkn1a, 
Col4a4, Adcy9, Plcb1, Cbl, Dvl3, 
Lama5, Prkacb, Lamb1, Rbx1, 
Gsk3b, Epas1, Rasgrp3, Traf6, 
Pdgfrb, Csf1r, Ptch1, F2r, Ednra, 
Bcl2, Hsp90aa1, Gng11, Hras 
18 Cdk6, Xiap, Ctnna3, Ccnd1, Cxcl12, 
Jak1, AC124712.1,Hif1a,Snapc1, 
Hif1a, AC124712.1,Hif1a, Snapc1, 
AC124712.1, Max, Lama5, Akt3, 
Fgf12, Igf1r, Rasgrp3, Epas1, Bcl2, 
Hsp90aa1, Cbl, Plcb1 
mmu04151 
 
PI3K-Akt 
signaling 
pathway 
38 Cdk6, Col5a3, Ccnd1, Angpt2, 
Jak1, Osmr, Thbs1, Fgf12, Thbs4, 
Syk, Sos1, Insr, Igf1r, Pik3cg, 
Prkaa2, Flt1, Gnb3, Cdkn1a, 
Col4a4, Sgk1, Itgb3, Irs1, Il4ra, 
Comp, Lama5, Lamb1, Gsk3b, 
Ccnd2, Angpt1, Pdgfrb, Csf1r, 
Thbs2, F2r, Kdr, Bcl2, Hsp90aa1, 
Gng11, Hras 
16 Cdk6, Pck1, Col5a3, Angpt2, 
Ccnd1, Jak1, Lama5, Akt3, Fgf12, 
Insr, Igf1r, Angpt1, Kdr, 
Agxt2,Gm21973,Prlr, Prlr, 
Gm21973, Agxt2, Bcl2, Hsp90aa1 
mmu04510 
 
Focal 
adhesion 
27 Col5a3, Ccnd1, Thbs1, Thbs4, 
Sos1, Igf1r, Pik3cg, Actb, Vcl, 
Flt1, Col4a4, Dock1, Itgb3, 
Arhgap35, Comp, Lama5, Lamb1, 
Gsk3b, Flnb, Ccnd2, Pdgfrb, 
Myl7, Myl9, Thbs2, Kdr, Bcl2, 
Hras 
11 Col5a3, Myl9, Myl7, Xiap, Ccnd1, 
Kdr, Bcl2, Lama5, Akt3, Igf1r, Flnb 
mmu04015 
 
Rap1 
signaling 
pathway 
23 Itgb3, Angpt2, Rap1gap, Thbs1, 
Fgf12, Itgb2, Insr, Igf1r, Pik3cg, 
Rasgrp3, Adcy4, Actb, Angpt1, 
Pdgfrb, Csf1r, F2r, Kdr, Flt1, Hras, 
Sipa1l2, Pfn2, Adcy9, Plcb1 
10 Rasgrp3, Angpt1, Angpt2, Kdr, 
Sipa1l1, Fgf12, Akt3, Insr, Plcb1, 
Igf1r 
mmu04152 
 
AMPK 
signaling 
pathway 
16 Irs1, Ccnd1, Adra1a, Scd1, Fbp2, 
Insr, Igf1r, Cpt1a, Scd4, Pik3cg, 
Irs2, Gm29427,Pfkfb2, Pfkfb2, 
C4bp-ps1, Gm29427, Prkaa2, 
Acaca, Pfkp, Acacb 
9 Cpt1a, Scd4, Pck1, 
Gm29427,Pfkfb2, Pfkfb2, C4bp-
ps1, Gm29427, Ccnd1, Akt3, 
Acacb, Insr, Igf1r 
mmu04066 
 
HIF-1 
signaling 
pathway 
15 Pdk1, Angpt2, 
AC124712.1,Hif1a,Snapc1, Hif1a, 
AC124712.1,Hif1a, Snapc1, 
AC124712.1, Nppa, Tfrc, Insr, 
Rbx1, Igf1r, Pik3cg, Eno1, 
Angpt1, Bcl2, Flt1, Cdkn1a, 
Gapdh 
9 Angpt1, Angpt2, 
AC124712.1,Hif1a,Snapc1, Hif1a, 
AC124712.1,Hif1a, Snapc1, 
AC124712.1, Bcl2, Akt3, Nppa, 
Tfrc, Insr, Igf1r 
S 2. KEGG pathways. Results from enriched RNA-seq analysis with the software DAVID, showing 
KEGG pathways shared by B6JPolgLar/Lar and B6JPolgPro/Pro. 
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Ensembl_gene_id gene sample_
1 
sample_
2 
log2  
(fold change) 
p_value significa
nt 
ENSMUSG00000030400 Ercc2 wt Pro -9.38509 0.00005 yes 
ENSMUSG00000076315 Ercc2 wt Pro -9.38509 0.00005 yes 
ENSMUSG00000094475 Gm11007 wt Pro -6.52118 0.00005 yes 
ENSMUSG00000026163 Sphkap wt Pro -4.42546 0.0003 yes 
ENSMUSG00000037263 Aldh3b3 wt Pro -4.14503 0.0002 yes 
ENSMUSG00000030046 Bmp10 wt Pro -3.99561 0.00005 yes 
ENSMUSG00000078894 2210418O10Rik wt Pro -3.52553 0.00015 yes 
ENSMUSG00000091971 Hspa1a wt Pro -3.31494 0.00005 yes 
ENSMUSG00000090877 Hspa1b wt Pro -2.86595 0.00005 yes 
ENSMUSG00000027694 Gm8325 wt Pro -2.80179 0.0003 yes 
ENSMUSG00000000730 Dnmt3l wt Pro -2.41181 0.00135 yes 
ENSMUSG00000068745 Mybphl wt Pro -2.29873 0.00005 yes 
ENSMUSG00000061086 Myl4 wt Pro -2.24657 0.00005 yes 
ENSMUSG00000020469 Myl7 wt Pro -2.10886 0.00005 yes 
ENSMUSG00000042045 Sln wt Pro -1.98314 0.00005 yes 
ENSMUSG00000054966 Lmntd1 wt Pro -1.96248 0.00005 yes 
ENSMUSG00000057880 Abat wt Pro -1.80074 0.00005 yes 
ENSMUSG00000029372 Ppbp wt Pro -1.77863 0.00005 yes 
ENSMUSG00000097039 Gm27718,Gm279
13,Gm27957,Pvt1 
wt Pro -1.74866 0.00085 yes 
ENSMUSG00000031594 Fgl1 wt Pro 1.95595 0.00005 yes 
ENSMUSG00000076441 Ass1 wt Pro 2.04998 0.00005 yes 
ENSMUSG00000030532 Hddc3 wt Pro 2.0604 0.00005 yes 
ENSMUSG00000003585 Sec14l2 wt Pro 2.08188 0.0001 yes 
ENSMUSG00000037254 Itih2 wt Pro 2.08439 0.00005 yes 
ENSMUSG00000027875 Hmgcs2 wt Pro 2.19103 0.00005 yes 
ENSMUSG00000073016 Uprt wt Pro 2.19736 0.00005 yes 
ENSMUSG00000010651 Acaa1b wt Pro 2.45203 0.00005 yes 
ENSMUSG00000021922 Itih4 wt Pro 2.5358 0.00005 yes 
ENSMUSG00000000416 Cttnbp2 wt Pro 2.57875 0.00135 yes 
ENSMUSG00000027513 Pck1 wt Pro 2.58106 0.00005 yes 
ENSMUSG00000025479 Cyp2e1 wt Pro 2.6205 0.00005 yes 
ENSMUSG00000020051 Pah wt Pro 2.89706 0.00005 yes 
ENSMUSG00000023070 Rgn wt Pro 2.93628 0.00005 yes 
ENSMUSG00000073424 Cyp4f15 wt Pro 3.18386 0.0012 yes 
ENSMUSG00000067235 H2-Q10 wt Pro 4.27889 0.00005 yes 
ENSMUSG00000039196 Orm1 wt Pro 4.51785 0.00105 yes 
ENSMUSG00000071177 Serpina1d wt Pro 5.27271 0.0008 yes 
ENSMUSG00000005681 Apoa2 wt Pro 5.57302 0.00005 yes 
ENSMUSG00000071178 Serpina1b wt Pro 5.62135 0.00005 yes 
S 3. RNA-Seq data comparing wild-type vs B6JPolgPro/Pro. Here are 20 genes with major and minor 
fold-change, comparing samples from heart of wild-type and B6JPolgPro/Pro animals.  
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Ensembl_gene_id gene sample_
1 
sample_
2 
log2  
(fold change) 
p_value significan
t 
ENSMUSG00000030400 Ercc2 wt Lar -9.43003 0.00005 yes 
ENSMUSG00000076315 Ercc2 wt Lar -9.43003 0.00005 yes 
ENSMUSG00000078875 Gm14419 wt Lar -5.35112 0.00005 yes 
ENSMUSG00000026163 Sphkap wt Lar -5.25188 0.0005 yes 
ENSMUSG00000091971 Hspa1a wt Lar -4.05656 0.00005 yes 
ENSMUSG00000078894 2210418O10Ri
k 
wt Lar -3.94501 0.00005 yes 
ENSMUSG00000037145 2210407C18Rik wt Lar -3.63439 0.00005 yes 
ENSMUSG00000067786 Nnat wt Lar -3.542 0.0002 yes 
ENSMUSG00000030046 Bmp10 wt Lar -3.47667 0.00005 yes 
ENSMUSG00000090877 Hspa1b wt Lar -3.43165 0.00005 yes 
ENSMUSG00000042045 Sln wt Lar -3.38066 0.00005 yes 
ENSMUSG00000061086 Myl4 wt Lar -3.32889 0.00005 yes 
ENSMUSG00000020469 Myl7 wt Lar -3.22487 0.00005 yes 
ENSMUSG00000024806 Mlana wt Lar -3.18349 0.0002 yes 
ENSMUSG00000022523 Fgf12 wt Lar -2.75532 0.00005 yes 
ENSMUSG00000097174 Gm4890 wt Lar -2.70718 0.00095 yes 
ENSMUSG00000020676 Ccl11 wt Lar -2.5498 0.00005 yes 
ENSMUSG00000034656 Cacna1a wt Lar -2.50141 0.00005 yes 
ENSMUSG00000076928 Trac wt Lar -2.46066 0.0002 yes 
ENSMUSG00000091754 Gm3636 wt Lar 1.90514 0.00005 yes 
ENSMUSG00000033713 Foxn3 wt Lar 1.92796 0.00005 yes 
ENSMUSG00000029752 Asns wt Lar 1.94073 0.00005 yes 
ENSMUSG00000043671 Dpy19l3 wt Lar 1.95512 0.00075 yes 
ENSMUSG00000048120 Entpd1 wt Lar 1.95788 0.00005 yes 
ENSMUSG00000019577 Pdk4 wt Lar 2.06959 0.00005 yes 
ENSMUSG00000020911 Krt19 wt Lar 2.07363 0.0002 yes 
ENSMUSG00000113626 Gm7240 wt Lar 2.08693 0.00035 yes 
ENSMUSG00000027171 Prrg4 wt Lar 2.26443 0.00005 yes 
ENSMUSG00000073016 Uprt wt Lar 2.26658 0.00005 yes 
ENSMUSG00000040270 Bach2 wt Lar 2.28524 0.00005 yes 
ENSMUSG00000108621 Gm37494 wt Lar 2.30048 0.00005 yes 
ENSMUSG00000040274 Cdk6 wt Lar 2.31608 0.00005 yes 
ENSMUSG00000050944 Efcab5 wt Lar 2.54003 0.00005 yes 
ENSMUSG00000099693 C130026I21Rik wt Lar 2.58907 0.001 yes 
ENSMUSG00000052477 C130026I21Rik wt Lar 2.58907 0.001 yes 
ENSMUSG00000054728 Phactr1 wt Lar 2.61499 0.00005 yes 
ENSMUSG00000045333 Zfp423 wt Lar 2.64954 0.00005 yes 
ENSMUSG00000027875 Hmgcs2 wt Lar 2.88928 0.00005 yes 
ENSMUSG00000006784 Ttc25 wt Lar 3.09629 0.00005 yes 
S 4. RNA-Seq data comparing wild-type vs B6JPolgLar/Lar. Here are 20 genes with major and minor 
fold-change, comparing samples from heart of wild-type and B6JPolgLar/Lar animals.  
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Ensembl_gene_id gene sample_
1 
sample_2 log2 
(fold_change) 
p_valu
e 
significan
t 
ENSMUSG00000032172 Olfm2 Lar Pro -3.91023 0.00005 yes 
ENSMUSG00000054728 Phactr1 Lar Pro -3.00076 0.00005 yes 
ENSMUSG00000003882 Il7r Lar Pro -2.526 0.00065 yes 
ENSMUSG00000006784 Ttc25 Lar Pro -2.28463 0.00005 yes 
ENSMUSG00000050944 Efcab5 Lar Pro -2.26762 0.00125 yes 
ENSMUSG00000108621 Gm37494 Lar Pro -2.18398 0.00005 yes 
ENSMUSG00000020911 Krt19 Lar Pro -2.18119 0.0017 yes 
ENSMUSG00000027694 Gm8325 Lar Pro -2.15679 0.00115 yes 
ENSMUSG00000017897 Eya2 Lar Pro -1.99926 0.00055 yes 
ENSMUSG00000044534 Ackr2 Lar Pro -1.85887 0.00115 yes 
ENSMUSG00000040270 Bach2 Lar Pro -1.80562 0.00005 yes 
ENSMUSG00000053093 Myh7 Lar Pro -1.75621 0.00005 yes 
ENSMUSG00000042985 Upk3b Lar Pro -1.73977 0.00005 yes 
ENSMUSG00000033713 Foxn3 Lar Pro -1.69733 0.00005 yes 
ENSMUSG00000060206 Zfp462 Lar Pro -1.61882 0.0004 yes 
ENSMUSG00000068606 Gm4841 Lar Pro -1.52094 0.0011 yes 
ENSMUSG00000063388 BC023105 Lar Pro -1.41701 0.00075 yes 
ENSMUSG00000037661 Gpr160 Lar Pro -1.40325 0.00005 yes 
ENSMUSG00000058297 Spock2 Lar Pro -1.27648 0.0002 yes 
ENSMUSG00000031722 Hp Lar Pro 2.56149 0.00005 yes 
ENSMUSG00000003585 Sec14l2 Lar Pro 2.71119 0.00005 yes 
ENSMUSG00000076441 Ass1 Lar Pro 2.72568 0.00005 yes 
ENSMUSG00000021922 Itih4 Lar Pro 2.835 0.00005 yes 
ENSMUSG00000046991 Wdr27 Lar Pro 2.90424 0.0018 yes 
ENSMUSG00000037145 2210407C18Ri
k 
Lar Pro 2.92637 0.00005 yes 
ENSMUSG00000023070 Rgn Lar Pro 2.94033 0.00005 yes 
ENSMUSG00000037686 Aspg Lar Pro 2.96896 0.00005 yes 
ENSMUSG00000050545 Fam228b Lar Pro 2.97243 0.00005 yes 
ENSMUSG00000024747 Aldh1a7 Lar Pro 3.11998 0.0004 yes 
ENSMUSG00000035875 AI182371 Lar Pro 3.12005 0.00005 yes 
ENSMUSG00000024039 Cbs Lar Pro 3.50781 0.0003 yes 
ENSMUSG00000031594 Fgl1 Lar Pro 3.85985 0.00005 yes 
ENSMUSG00000030382 Slc27a5 Lar Pro 3.92464 0.00005 yes 
ENSMUSG00000067235 H2-Q10 Lar Pro 4.00268 0.00005 yes 
ENSMUSG00000005677 Nr1i3 Lar Pro 4.38082 0.00045 yes 
ENSMUSG00000078875 Gm14419 Lar Pro 4.68799 0.00005 yes 
ENSMUSG00000071177 Serpina1d Lar Pro 5.87702 0.00085 yes 
ENSMUSG00000005681 Apoa2 Lar Pro 5.90351 0.00005 yes 
ENSMUSG00000071178 Serpina1b Lar Pro 6.45816 0.00005 yes 
S 5. RNA-Seq data comparing B6JPolgLar/Lar and B6JPolgPro/Pro. Here are 20 genes with major and 
minor fold-change, comparing samples from heart of B6JPolgLar/Lar and B6JPolgPro/Pro
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Position dbSNP RNA-
Seq 
data 
Pro 
Allele 
RNA-
Seq 
data 
Lar 
allele 
Ref 
(GRCm38.p6 ) 
SNPs 
in 
other 
strains 
Consequences 
79449299 rs254447053 G* A A G* 3_prime_utr_variant 
nmd_transcript_variant 
downstream_gene_variant 
79449424 rs37134955 T* C C T* 3_prime_utr_variant 
nmd_transcript_variant 
downstream_gene_variant 
79450709 rs32308962 - - T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79451929 rs31834612 G* A A G* synonymous_variant 
3_prime_utr_variant 
nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79452000 rs31713195 C* A A C* missense_variant 
3_prime_utr_variant 
nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79453448 rs31806755 - - G A* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79453971 rs31526362 - - G A* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79454512 rs31213966 G* A A G* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79455788 rs32518466 - - G T* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79455892 rs32139899 - - A G* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79455965 rs31429820 - - T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79456727 rs31546017 T* C C T* missense_variant 
3_prime_utr_variant 
nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79456913 rs31899011 - - A G* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79457291 rs32191422 A* T T A* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79457967 rs32327250 - - C A* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
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79457974 rs31335373 - - C T* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79458032 rs32473070 - - T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79458034 rs31101233 - - G A* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79459013 rs31334366 - - C T* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79459026 rs32480059 - - C T* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79459254 rs13465959 C* T T C* synonymous_variant 
3_prime_utr_variant 
nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79459385 rs32158620 - - T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79459652 rs31277724 - - A C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79460563 rs31419114 G* A A G* missense_variant 
nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79460717 rs32306699 T* G G T* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79460773 rs31924510 - - C T* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79461274 rs31160733 C* T T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79461669 rs31991119 C* T T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79461670 rs32333834 C* T T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79461818 rs32472336 T* G G T* synonymous_variant 
nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79462408 rs31617548 - - T C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79463291 rs265473164 - - G C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79463506 rs31943710 A* G G A* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
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79463737 rs49532739 - - A C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79464290 rs3674989 - - A C* nmd_transcript_variant 
upstream_gene_variant 
downstream_gene_variant 
79464990 rs31639173 T* G G T* synonymous_variant 
nmd_transcript_variant 
upstream_gene_variant 
79465133 rs31192147 C* A A C* missense_variant 
nmd_transcript_variant 
upstream_gene_variant 
79465635 rs31625700 A* G G A* nmd_transcript_variant 
upstream_gene_variant 
79465778 rs31579544 C* A A C* nmd_transcript_variant 
upstream_gene_variant 
79466081 rs31555652 C* T T C* 5_prime_utr_variant 
nmd_transcript_variant 
upstream_gene_variant 
S 6. Table with all the SNPs described in the POLG allele and data from RNA-Seq. The first 
column shows the position in the POLG gene. The second column shows the ID from the Single 
Nucleotide Polymorphism Database (dbSNP). The third and fourth column shows the data from the 
RNA-Seq data obtained from hearts of B6JPolgLar/Lar and B6JPolgPro/Pro mice at 35 weeks. The fifth 
column shows the nucleotide from the reference sequence GRCm38.p6. The sixth column shows the 
SNPs from the strains 129S, C3H, CBA, DBA, KK_HiJ and SEA_GnJ substrains. Data obtained from 
the Mouse Genomes Project - Gene: Polg; Chr: 7:79,448,791-79,466,362 (ftp://ftp-
mouse.sanger.ac.uk/REL-1505-SNPs_Indels) from the Sanger Institute. The seventh column shows the 
consequences of these SNPs.  
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S 7. Toludine staining. Toluidine staining in heart, colon and skeletal muscle of mice at 35 weeks old.  
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S 8. In organello assay in mitochondria isolated from heart of 38 week-old mice. We show the 
samples from the denatured pulse and native pulse, with the corresponding mtDNA steady state using 
the probe PAM1, and protein input by Western blot with VDAC as a control. B) Quantification of de 
novo mtDNA, de novo 7s and de novo 7s smear. Signals normalized to the mtDNA steady state with 
PAM1.  
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7. MATERIALS AND METHODS 
7.1. Generation and Maintenance of Mice  
?????? ????????????????
All mice were maintained in individually ventilated cages at the Max Planck Institute for 
Biology of Ageing (MPI-AGE). Cages conditions were at constant temperature of 21°C, 50 
- 60% of humidity and with a 12 h light/dark cycle. Mice were fed ad libitum. Experiments 
were approved by the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen (LANUV) in accordance with German and European Union regulations (ID 84-
02.04.2015.A103). All procedures were performed following the recommendations of the 
Federation of the European Laboratory Animal Science Association (FELASA) 
recommendations. 
 
?????? ?????????????????????????????? ?????? ????
Wild-type C57BL/6J mice and mutator B6JPolgPro/Pro (strain name B6.129S7(Cg)-
Polgtm1Prol/J) mice were purchased from Charles River Company in Germany. Wild-type 
C57BL/6NCrl mice and mutator B6NPolgLar/Lar were obtained from Professor Nils-Göran 
Larsson. To avoid maternally transmitted mutations in the mutator mice, each mutant line 
was maintained backcrossing wild-type females with heterozygous mutant males. To obtain 
homozygous animals, male and female heterozygous mutants were crossed. 
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7.2. Molecular biology methods 
?????? ?????????????????
For genotyping, DNA from tail or ear-clip biopsies of two-three week old pups were 
extracted using 70 ul of buffer I (25mM NaOH, 0.2mM EDTA) and incubated for 45 min 
at 96°C. Later, samples were incubated a few minutes on ice and 70 ul of buffer II (40mM 
Tris pH 7.5 -8) was add it. Samples were storage at 4 °C until use. 
Sample DNA 1 ul 
dH2O 10 ul 
Buffer 5X 4 ul 
dNTPs (1.25 mM each) 3.2 ul 
Primer Fw (100uM) 0.8 ul 
Primer Rev  (100uM) 0.8 ul 
GoTaq  0.1 ul 
Table 7-1. General PCR reaction mix 
 
Stage Step Temperature 
(°C) 
Time  Expected Products 
1 cycle 1 95°C 1 min Wild-type: ~520 bp  
Heterozygous: ~720 + ~520 bp 
Homozygous: ~720bp (mutator) 
30 cycles 1 
2 
3 
95°C 
58 °C 
72°C 
30 sec 
30 sec 
45 sec 
1 cycle 1 
2 
72°C 
8°C 
2min 
∞ 
Table 7-2. POLG PCR Program to amplify Lar allele. 
 
Stage Step Temperature 
(°C) 
Time  Expected products 
1 cycle 1 94°C 3 min Wild-type: ~300 bp 
Heterozygous: ~500 + ~300 bp  
Homozygous: ~500 bp (mutator)
  
10 cycles 1 
2 
3 
94°C 
65 (°C) 
68°C 
20 sec 
15 sec 
10 sec 
28 cycles 1 
2 
3 
94°C 
60 (°C) 
72°C 
15 sec 
15 sec 
10 sec 
1 cycle 1 
2 
72°C 
8°C 
2min 
∞ 
Table 7-3. POLG PCR Program to amplify Pro allele. 
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Stage Step Temperature 
(°C) 
Time  Expected Products 
1 cycle 1 95°C 1 min Wild-type: <700 bp 
mut: >700 bp 
KO= ~399 bp  
30 cycles 1 
2 
3 
95°C 
55 °C 
72°C 
30 sec 
30 sec 
45 sec 
1 cycle 1 
2 
72°C 
8°C 
2min 
∞ 
Table 7-4 POLG PCR Program to amplify KO allele. 
 
Allele to detect Genotyping primers (5’-3’)  
Pro 
(genotyping) 
CTCGCTTTCTCCGTGACTG 
ATGTGGCCCAGGCTGTAACT 
Lar 
(genotyping) 
CTTCGGAAGAGCAGTCGGGTG  
GGGCTGCAAAGACTCCGAAGG  
KO 
(genotyping) 
CTTCGTCGATCGACCTCGAATAAC 
CTGCCATTCACCTTACCC 
GGATGGGCAGGAACAGTTAG 
WANCY  
(to detect mtDNA) 
AGTATAGTAATGCCTGCGGC 
CCTACCCTAGCCCCCC 
Table 7-5 List of primers used for the PCR 
 
?????? ?????????????????
Blood (~500ul) was sent to LABOKLIN (LABOKLIN GMBH & CO.KG, Labor Für 
Klinische Diagnostik) in heparin coated blood collection tubes. The laboratory performed 
complete blood count with flow cytometry incl. peroxidase stain.  
 
?????? ??????????????????
Protocol from Isokallio et al., (2018) was followed. Briefly, fresh tissue (~300 mg liver) 
was cut into small pieces and washed with PBS (Thermo Fisher, 14190). All procedures 
were performed at 4°C, unless another temperature is indicated. Tissue was homogenized 
with 10 teflon pestle strokes at 200 rpm in buffer MIB1 (320 mM sucrose, 20 ml Tris-HCl, 
1 mM EGTA, 0.2% BSA, pH 7.2).  Then, mitochondria were differential centrifugation 
purified (two times at 800 g for 10 min and 1 time at 8,500 g for 10 min). The resulting 
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mitochondrial pellet was re-suspended in 1.4 mL of Mito-DNase buffer (300 mM sucrose, 
10 mM MgCl2, 20 mM Tris HCl, pH 7.5, 0.15% BSA, 0.03 mg/ml DNase I type IV, 170 
ng/μl RNase A), and incubated for 1 hr at 37°C. Subsequently, mitochondria were pelleted 
at 13 000 g, for 15 min and washed with 500 μl of MIB02 (320 mM sucrose, 20 ml Tris-
HCl, 1 mM EGTA, 0.2% BSA, pH 7.2), two times. Then, samples were fast-frozen in liquid 
nitrogen and stored at -80° C until use.  
The frozen mitochondrial pellets were re-suspended in 400 μl of lysis buffer (20 mM Tris 
HCl, 150 mM NaCl, 20 mM EDTA, 1% SDS, pH 8.7, 0.2 mg/mL Proteinase K and 0.2 
mg/ml RNase A). Samples were incubated at 56°C overnight. The next day, the samples 
were cooled down at room temperature. To extract the mtDNA, 100 ul of 6M potassium 
acetate was added, then 500 μl of chloroform:isoamylalcohol 24:1 (Thermos Fisher, 
AM9720) was added. The tubes were shaken for 20 sec.  
200 μg RNase A (Macherey-Nagel, CAS 9001-99-4) was added and incubated for 45-60 
min at 37°C. To precipitate the DNA, 1 mL of cold ethanol was added. Samples were 
incubated for 1 hr at -80 ℃ (or overnight at -20 ℃).  Finally, samples were centrifuged at 
16,000g at room temperature, and the pellet was re-suspended in 25 μl of AE buffer (5 mM 
Tris/HCl pH 8.5, Macherey-Nagel). Quantification was performed with a fluorometric 
method, using the reagents dsDNA Qubit (ThermoFisher, Q32850). The mtDNA purity 
(nuclear DNA free) was confirmed by the lack of amplification using Lar or Pro primers 
and by the amplification using mtDNA specific “WANCY” primers Table 7-5.  
 
?????? ??????????????????????
Total DNA was extracted from snap-frozen tissues with Gentra Puregene Tissue Kit 
(QIAGEN, 51404), following the indicated manufacturer’s recommendations. For qPCR, 
DNA was treated with RNase (Macherey-Nagel, CAS 9001-99-4) during DNA extraction 
according to the QIAGEN protocol. DNA concentration was determined with the 
spectrophotometer NanoDrop 2000c (Thermo Fisher). 
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?????? ?????????????????????
Ground, snap-frozen mouse tissues were homogenized using lysing matrix D (MPBio) prep 
machine with two pulses of 30 sec at speed 6. The homogenization step was repeated after 
5 min incubation at 4 ℃. Next, TRIzol LS reagent (Thermo Fisher, 10296028) was used to 
extract total RNA, following the manufacturer’s instructions. The isolated RNA was DNase 
treated using the TURBO DNA-free kit (Ambion, AM2238), according to manufacturers’ 
instructions. The RNA concentration was determinate with the spectrophotometer 
NanoDrop 2000c (Thermo Fisher). The RNA integrity was analyzed in agarose-SDS gel 
(1% agarose, 0.1%SDS). RNA purity (DNA free) was confirmed by the lack of 
amplification using Lar or Pro PCR primers.  
 
?????? ???????????????
cDNA was generated from RNA (DNase treated) using the High Capacity cDNA reverse 
transcription kit (Thermo Fisher,4368814), following manufacturers’ instructions.  
 
?????? ?????????????????
qPCR and RT-qPCR were performed using the Taqman 2x Universal PCR mastermix 
(Applied Biosystems, 4324020) and commercially available Taqman probes (Life 
technologies), on a QuantStudio 6 RealTime PCR System (Applied Biosystems). All 
reactions were made in triplicates with 5 ng of total DNA or cDNA (diluted 1:10 or 1:30), 
using 1 ul of sample per reaction (final volume 10 μl).  The amplification data were analyzed 
with a standard-curve method using an artificial curve (mix of samples).  
Probe Name Assay ID 
POLG Mitochondrial Polymerase gamma, exon boundary 
2-3 
Mm00450527_m1  
POLG  Mitochondrial Polymerase gamma, exon boundary 
3-4 
Mm00450528_m1  
TBP TATA-box binding protein Mm00446973_m1 
B2M beta2-microglobulin Mm00437762_m1 
18s 18s rRNA-housekeeping gene Hs99999901_s1 
16s mt 16s rRNA (Rnr2) Mm04260181_s1 
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ND2 mt NADH dehydrogenase 2 Mm04225288_s1 
ND4 mt NADH dehydrogenase 4 Mm04225294_s1 
Table 7-6 List of Taqman Probes 
 
?????? ??????????????????
5 ug of DNA was digested over night at 37℃ with SacI-HF enzyme (New England BioLabs, 
R3156), following manufacturers’ instructions. Then, DNA was precipitated with 8 ul of 
5M NaCl and 500 ul of ethanol 95%. Samples were incubated overnight at -80 °C and 
centrifuged at 13,000 rpms at room temperature. Pellet was washed with ethanol 75% and 
DNA re-suspended in 20 ul of TE buffer. The DNA was quantified by nanodrop. 
Subsequently, 5 ul of DNA was loaded with 6X loading dye (New England Biolabs, 
B7024S) and DNA separated on a 0.8 % agarose gel, running at 40 volts for about 16 hours.  
Gel was pre-treated with 0.2 M HCl for 20 minutes, two washes with water (5 minutes each), 
denaturizing solution (1.5 M NaCl and 0.5 M NaOH) for 20 minutes,  two washes with 
water (5 minutes each), and neutralization solution (1.5 M NaCl and 0.5 M Tris-HCl pH 
7.4) for 20 minutes. Hybond-N+ membrane (Amersham, RPN303B) was incubated in water 
for 10 min. Then, the gel and membrane were incubated for 20 minutes in 20x SSC (3 M 
Sodium chloride and 300 mM tri-Sodium citrate dihydrate, pH 7.0). The Southern blot was 
assembled with whatman paper, membrane, gel, whatman paper, and paper tower to transfer 
the DNA.  The transfer was performed for approximately 48 hours.  The membrane was 
UV-cross-linked and labeled with a radioactive probe.  
For radioactive labeling, DNA probes were radioactive-labelled with [α-32P] dCTP 
(Hartmann Analytic, Catalog #srp-205) using Prime-It® II Random Primer Labeling Kit 
(Agilent, catalog #300385), following manufacturers’ instructions. Then the probe was 
purified with the kit ProbeQuant G-50 Micro Columns (GE Healthcare, 28903408) 
according to manufacturers’ instructions. Next, the membrane was incubated in Perfect Hyb 
Plus hybridization buffer (Sigma-Aldrich, H7033) for one hour and then, incubated at 65 
°C overnight with radioactive probes and random primers (Roche, 11034731001). 
Membranes were washed in 2X SSC, 0.1% SDS, 15 min at room temperature and 15 min 
at 65 °C. In the end, the membrane was sealed in a plastic bag, exposed to a phosphor screen, 
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and developed using the PhosphorImager instrument Typhoon FLA 7000 (GE healthcare). 
Quantifications were performed using the software MultiGauge (v3.0).  
Probe Sequence 
18S GGTCTACAAGACGCCACATCCCCTATTATAGAAGAGCTAATAAATTTC
CATGATCACACACTAATAATTGTTTTCCTAATTAGCTCCTTAGTCCTCT
ATATCATCTCGCTAATATTAACAACAAAACTAACACATACAAGCACAA
TAGATGCACAAGAAGTTGAAACCATTTGAACTATTCTACCAGCTGTAA
TCCTTATCATAATTGCTCTCCCCTCTCTACGCATTCTATATATAATAGAC
GAAATCAACAACCCCGTATTAACCGTTAAAACCATAGGGCACCAATGA
TACTGAAGCTACGAATATACTGACTATGAAGACCTATGCTTTGATTCAT
ATATAATCCCAACAAACGACCTAAAACCTGGTGAACTACGACTGCTAG
AAGTTGATAACCGAGTCGTTCTGCCAA 
pAM1 Entire mouse mtDNA cloned in pAcyc177  
7s DNA Entire mouse control region (15423..16299) cloned to pCRIITOPO ACR 
Table 7-7. Probes for Southern blotting 
 
?????? ???????????????????????????????
In organello replication was performed on freshly isolated mitochondria from mouse hearts 
by differential centrifugation as described in method 7.2.10. Mitochondria were quantified 
with DC protein quantification assay (Method 7.3.1). 1 mg of freshly isolated mitochondria 
were re-suspended in transcription labeling buffer (25 mM sucrose, 75 mM sorbitol, 100 
mM KCl, 10 mM K2HPO4, 50 μM EDTA, 5 mM MgCl2, 1 mM ADP, 10 mM glutamate, 
2.5 mM malate, 10 mM Tris pH 7.4, 1 mg/ml of bovine serum albumin (BSA), and 1 mM 
ADP). 50 uM of each dNTP (except dATP) and 20uCi of [α-32P] adenosin-5’-triphoshphate 
(dATP) was added. Samples were incubated at 37°C for 2 hours. An aliquot was taken for 
chase and incubated for 1 extra hour. Later, mitochondria were pelleted at 9000 rpms for 4 
min at 4 °C, and mitochondria washed two times in washing buffer (10% glycerol, 10 mM 
Tris-HCl pH 6.8, and 0.15 mM MgCl2). An aliquot was taken for western blot analysis 
(Method 7.3.2.). The pellet was re-suspended in 150 ul of PK buffer (50	mM	TrisHCl	pH	
7.4,	75	mM	NaCl,	6	mM	EDTA	and	1%	SDS).	Then,	with	200	ul	of	phenol/chloroform,	
the	samples	were	shaken	for	20	seconds	and	centrifuged	at	16,000	g	for	5	minutes.	
DNA	was	 precipitated	 adding	 50	 ul	 5M	Ammonium	 acetate	 and	 250	 ul	 cold	 100%	
ethanol.	The	tubes	were	placed	at	‐20°C for at least 3 hours and centrifuged for 20 min at 
4°C. Then, ethanol was removed and the pellet was re-suspended in 30 ul of TE solution 
(QIAGEN, 1018499). DNA was loaded in an agarose gel 0.8% and ran at 90V for 160 min. 
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Subsequently, the gel was transferred to Hybond-N+ membrane (Amersham, RPN303B) as 
previously described (Method 7.2.8). In the end, the membrane was sealed in a plastic bag 
and exposed to a phosphor screen and developed using the PhosphorImager instrument 
Typhoon FLA 7000 (GE healthcare). Quantifications were performed using the program 
MultiGauge (v3.0).  
 
??????? ????????????? ???????????????????????
Mice were euthanized and the heart extracted. The heart was rinsed and cut in ice-cold PBS 
(Thermo Fisher, 14190). The tissue was placed in a 5 ml Potter S homogenizer containing 
5 ml of isolation buffer (320 mM sucrose, 1 mM EDTA, 10 mM Tris-HCl pH 7.4 and 1X 
Roche complete protease inhibitors). The tissue was homogenized in the Homogen plus 
homogenizer (Schuett-biotech) with 16 strokes at 300 rpm. 5 mL of isolated buffer was 
added and samples centrifuged for 10 minutes at 1,000 rcf and 4°C. Supernatants were 
transferred into a new tube and centrifuged at 1000 rcf. Then, mitochondria pelleted was 
centrifuged 10,000 rcf for 10 minutes at 4°C. Crude mitochondria were suspended in 
isolation buffer and used for in organello assay or stored at -80°C until use. 
 
??????? ???????????????
Cauda region epididymis of mice was clamped proximally and distally by Dr. Jiang. Tissue 
was rinsed in pre-warmed (37°C) PBS (Thermo Fisher, 14190). Later, the tissue was placed 
in pre-warmed (37°C) M2 medium (SIGMA). The cauda epididymis was then unclamped 
and pierced with a scalpel blade to release the sperm. Then, sperm were allowed to disperse 
for 10 min at 37°C. Sperm relative number and sperm motility were determinate by CASA 
detection (Hamilton Thorne Research) at the Transgenesis core facility. To determine sperm 
morphology, sperm were spread on glass slides and fixed with 4% PFA (X). Subsequently, 
slides were stained with H&E (Method 7.3.5). Deformities were classified according to 
(Wyrobek and Bruce, 1975).  
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7.3. Biochemical methods 
?????? ?????????????????
Protein quantification was determinate using DC Protein Assay (BioRad, LIT448), 
following the standard assay protocol from manufacturers’ instructions. 
 
?????? ?????????????????
Isolated mitochondria pellet were re-suspended in 4X NuPAGE LDS sample buffer 
(Invitrogen, NP0007) with 50 mM DTT. Proteins were separated using precast gels 4-12% 
Bis-Tris (Invitrogen, WG1402BOX) and the electrophoretic NuPAGE system (Invitrogen). 
The gel was wet-transferred to a PVDF membrane (Merck, IPVH00010), with transfer 
buffer (38.6 mM Tris, 47.8 mM glycine, 20% methanol), using a Criterion blotter chamber 
(Bio-Rad). Next, the membrane was blocked with 5% milk in T-TBS (150 mM NaCl, 50 
mM Tris-HCl pH 7.6 and 0.05% TWEEN-20). Primary antibodies were also diluted in T-
TBS 5% milk, followed by 3 washes with T-TBS. Secondary antibodies with horseradish 
peroxidase-linked were also diluted in T-TBS 5% milk, followed by 3 washes with T-TBS. 
Final wash was performed with PBS (Thermo Fisher, 14190). Visualization was obtained 
with chemioluminescence ECL Western Blotting Detection Reagent (GE Healtcare Life 
Sciences, RPN2106) and imaging system (LI-COR Biosciences). 
 
Antibody Company Cataloge 
Number 
Dilution 
POLG Abcam ab128899 1:500 
VDAC Abcam ab14734 1:1,000 or 1:10,000 (isolated 
mitochondria) 
TOM20 Santa Cruz 
Biotechnology 
sc-11415 1:5,000 
TFAM Abcam ab131607 1:1,000 
Secondary Anti- 
Mouse, HRP 
Merck NXA931 1:5,000 
Secondary Anti-
Rabbit, HRP 
Thermo Fisher g21234 1:5,000 
Table 7-8. List of Antibodies and dilutions. 
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?????? ??????????????
For Nitrotetrazolium Blue Exclusion Assay (NBTx), tissue sections of 10 um (colon and 
skeletal muscle) and 7 um (heart) of tissue was generated in the cryostat at the FACS & 
Imaging core facility. Samples were incubated 10 min with 1mL PBS, then the PBS was 
discarded. 1 mL of NBTx solution was added (130 mM sodium succinate, 200 μM 
phenazinemethosulphate, 1.5 mM nitroblue tetrazolium in 0.2 M phosphate buffer pH 7.0). 
Then, sections were washed for 5 min with PBS (PBS, 0.1 M, pH 7.0). Dehydration was 
performed through graded ethanol series: 2 min in 50%, 2 min in 75%, 2 min in 96%, 2 min 
in 100%, and 5 min in 100%. Finally, slides were incubated in two Xylene changes, 5 min 
each. Mounting was performed with Cystoseal (Thermo Scientific, 8312-4). Imaging was 
performed with Nikon Eclipse Ci Microscope at the FACS & Imaging core facility. Image 
mitochondrial dysfunction quantification was performed with Image J software, following 
image settings and macro specifications as previously described by Simard et al., (2018).  
 
?????? ?????????????????
For cytochrome c oxidase (COX)/ succinate dehydrogenase (SDH) enzyme histochemistry 
(COX-SDH), tissue sections of 10 um of the colon were generated in the cryostat at the 
FACS & Imaging core facility. Slide samples were incubated at 37 °C in 100 μl of COX 
staining medium (100 μM cytochrome c, 4 mM diaminobenzidine tetrahydrochloride, 20 
μg/ml catalase in 0.2 M phosphate buffer pH 7.0) for 45 min. Subsequently, the sections 
were washed 3 times with PBS for 5 min. Next, samples were incubated at 37 °C for 20 min 
in 50 μl of SDH solution (130 mM sodium succinate, 200 μM phenazinemethosulphate, 1 
mM sodium azide, 1.5 mM nitroblue tetrazolium in 0.2 M phosphate buffer pH 7.0). Then, 
sections were washed 3 times for 5 min with PBS (PBS, 0.1 M, pH 7.0). Dehydration was 
performed through graded ethanol series: 2 min in 50%, 2 min in 75%, 2 min in 96%, 2 min 
in 100%, and 5 min in 100%. Finally, slides were incubated in two Xylene changes, 5 min 
each. Mounting was performed with Cystoseal (Thermo Scientific, 8312-4). Imaging was 
performed with Nikon Eclipse Ci Microscope at the FACS & Imaging core facility. 
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?????? ?????????????
Sperm and heart sections were fixed with 4% Paraformaldehyde (Sigma-Aldrich, 28908). 
Haematoxylin and Eosin Y staining was performed using Gemini AS Automated Slider 
(Thermo Fisher), according to manufactures protocol. Solutions used were Haematoxylin 
(AppliChem) and Eosin Y (Carl Roth). Imaging was performed with Nikon Eclipse Ci 
Microscope at the FACS & Imaging core facility. 
 
?????? ???????????????????
Tissue sections of 10 um (colon and skeletal muscle) and 7 um (heart) thickness were fixed 
with 4% Paraformaldehyde (Sigma-Aldrich, 28908). Then, 1 mL of Toluidine solution was 
added (Toluidine blue 0.1% in 1% sodium chloride at pH 2.3) and incubated for 3 minutes 
at room temperature. Sections were washed 3 times in dH20 and dehydrated (fast dipping a 
few times, first in 95%, then 100% and 100% again). Finally, slides were incubated in 
Xylene for 5 minutes, two times. Mounting was performed with Cytoseal (Thermo 
Scientific, 8312-4). Imaging was performed with Nikon Eclipse Ci Microscope at the FACS 
& Imaging core facility. 
 
7.4. Sequencing  
?????? ?????????????????????????????????
Total RNA samples (~1.5 ug) from the heart were sent for sequencing at Max-Planck 
Genome-center Cologne (MP-GC). Sequencing was performed in Illumina HiSeq3000, 
paired-end mode, using TruSeq compatible directional RNA library. The sequencing 
libraries were prepared by the MP-GC. Analysis of the row data, determination of fold 
change expression, KEGG pathways and MD plots were performed by the Bioinformatics 
Core Facility.  
Mitochondrial related genes analysis was performed using the web-platform mitoXplorer 
v.1.0 (http://mitoxplorer.ibdm.univ-mrs.fr/), using only genes with an adjusted p-value 
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<0.05.  Functional enrichment analysis was performed in software QIAGEN’s Ingenuity® 
Pathway Analysis (IPA®, https://www.qiagenbioinformatics.com/products/ingenuity-
pathway-analysis/).  
 
?????? ?????????????????
Enriched mtDNA samples (>100 ng) from the liver were sent for sequencing at Max-Planck 
Genome-center Cologne (MP-GC). Sequencing was performed in Illumina HiSeq3000 in 1 
x 150bp mode, using TruSeq compatible DNA library. The sequencing libraries were 
prepared by the MP-GC. Data were analyzed by the Bioinformatics Core Facility. 
 
?????? ???????????????
Allele quantification was performed by pyrosequencing PyroMark Q24 Pyrosequencer 
(QIAGEN) on cDNA from heart, colon, liver and skeletal muscle of compound 
heterozygous mice B6JPolgLar/Pro. First, a PCR was performed to amplify from exon 3 to 
exon 4 (see table primers forward and revers), and from exon 3 to intron 3-4 (see table 
primers forward and revers). Second, PCR products were combined with binding buffer, 
Streptavidin sepharose TM high performance beads (GE Healthcare, GE17-5113-01) 
annealing buffer (QIAGEN, 979009) and primer for sequencing (see table, 7-9) in the 
Pyromark Q24 vacuum workstation (QIAGEN) according to manufacturer’s instructions. 
Finally, sequencing was performed with PyroMark Gold Q24 reagents (QIAGEN, 970802) 
following the manufacturer’s instructions.  
 
Exon 3  to exon 4 Forward [Btn]TGGTGGGGCACAATGTTTC 
Reverse AGCTGCTCAGCCCCGAGAT 
For Sequencing CCTGATATGGGCTCG 
Exon 3 to intron 3-4 Forward AGTTAGTGGTGGGGCACAAT 
Reverse [Btn]TGGAAACAGTCACGGAGA 
For Sequencing TGGAAACAGTCACGGAGA 
Table 7-9. List of primers used for Pyrosequencing 
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7.5. Statistical analysis 
?????? ??????????????????????????????????????
Data graphs and statistical analyses were done using GraphPad Prism 5 software. For all 
experiments, the data were assumed to follow a normal distribution. Data are presented as 
means ± SEM (standard error of the mean). Statistical comparisons between more than two 
groups were performed using one-way analysis of variance (ANOVA) in multiple 
comparisons, with post hoc analysis conducted with Tukey’s multiple comparison test. For 
two groups Student’s t test was performed. Statistical significance was considered if at P< 
0.05 (*p<0.05; **p<0.01; ***p<0.001). All statistical parameters are outlined at the figure 
legends. 
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